<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Colloids versus crystalloids for fluid resuscitation in critically ill people - Lewis, SR - 2018 | Cochrane Library</title> <meta content="Colloids versus crystalloids for fluid resuscitation in critically ill people - Lewis, SR - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000567.pub7/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Colloids versus crystalloids for fluid resuscitation in critically ill people - Lewis, SR - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000567.pub7/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000567.pub7" name="dc.identifier" scheme="DOI"/> <meta content="Colloids versus crystalloids for fluid resuscitation in critically ill people" name="citation_title"/> <meta content="Sharon R Lewis" name="citation_author"/> <meta content="Royal Lancaster Infirmary" name="citation_author_institution"/> <meta content="Sharon.Lewis@mbht.nhs.uk" name="citation_author_email"/> <meta content="Michael W Pritchard" name="citation_author"/> <meta content="Royal Lancaster Infirmary" name="citation_author_institution"/> <meta content="David JW Evans" name="citation_author"/> <meta content="Lancaster University" name="citation_author_institution"/> <meta content="Andrew R Butler" name="citation_author"/> <meta content="Royal Lancaster Infirmary" name="citation_author_institution"/> <meta content="Phil Alderson" name="citation_author"/> <meta content="National Institute for Health and Care Excellence" name="citation_author_institution"/> <meta content="Andrew F Smith" name="citation_author"/> <meta content="Royal Lancaster Infirmary" name="citation_author_institution"/> <meta content="Ian Roberts" name="citation_author"/> <meta content="London School of Hygiene &amp; Tropical Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD000567.pub7" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/08/03" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000567.pub7/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000567.pub7/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000567.pub7/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Rehydration Solutions; Colloids [adverse effects, *therapeutic use]; Critical Illness [mortality, *therapy]; Crystalloid Solutions [adverse effects, *therapeutic use]; Fluid Therapy [*methods, mortality]; Isotonic Solutions; Plasma Substitutes [*therapeutic use]; Randomized Controlled Trials as Topic; Renal Replacement Therapy [statistics &amp; numerical data]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000567.pub7&amp;doi=10.1002/14651858.CD000567.pub7&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="6XSHdtL3";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000567\x2epub7\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000567\x2epub7\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","fr","fa","es","zh_HANS","de","ru","pt","ms","ja","zh_HANT","hr","ko"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000567.pub7",title:"Colloids versus crystalloids for fluid resuscitation in critically ill people",firstPublishedDate:"Aug 3, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Injuries Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6XSHdtL3&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000567.pub7&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000567.pub7';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000567.pub7/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000567.pub7/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000567.pub7%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000567.PUB7" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000567.pub7/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000567.PUB7" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000567.pub7/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000567.pub7/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>65794 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000567.pub7" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-sec-0152"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-sec-0041"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-sec-0042"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-sec-0066"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-sec-0146"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/appendices#CD000567-sec-0157"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/table_n/CD000567StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/table_n/CD000567StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Colloids versus crystalloids for fluid resuscitation in critically ill people</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information#CD000567-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Sharon R Lewis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information#CD000567-cr-0003">Michael W Pritchard</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information#CD000567-cr-0004">David JW Evans</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information#CD000567-cr-0005">Andrew R Butler</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information#CD000567-cr-0006">Phil Alderson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information#CD000567-cr-0007">Andrew F Smith</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information#CD000567-cr-0008">Ian Roberts</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information/en#CD000567-sec-0169">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 03 August 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000567.pub7">https://doi.org/10.1002/14651858.CD000567.pub7</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000567-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000567-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000567-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000567-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000567-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000567-abs-0019">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD000567-abs-0003">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000567-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000567-abs-0001" lang="en"> <section id="CD000567-sec-0001"> <h3 class="title" id="CD000567-sec-0001">Background</h3> <p>Critically ill people may lose fluid because of serious conditions, infections (e.g. sepsis), trauma, or burns, and need additional fluids urgently to prevent dehydration or kidney failure. Colloid or crystalloid solutions may be used for this purpose. Crystalloids have small molecules, are cheap, easy to use, and provide immediate fluid resuscitation, but may increase oedema. Colloids have larger molecules, cost more, and may provide swifter volume expansion in the intravascular space, but may induce allergic reactions, blood clotting disorders, and kidney failure. This is an update of a Cochrane Review last published in 2013. </p> </section> <section id="CD000567-sec-0002"> <h3 class="title" id="CD000567-sec-0002">Objectives</h3> <p>To assess the effect of using colloids versus crystalloids in critically ill people requiring fluid volume replacement on mortality, need for blood transfusion or renal replacement therapy (RRT), and adverse events (specifically: allergic reactions, itching, rashes). </p> </section> <section id="CD000567-sec-0003"> <h3 class="title" id="CD000567-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase and two other databases on 23 February 2018. We also searched clinical trials registers. </p> </section> <section id="CD000567-sec-0004"> <h3 class="title" id="CD000567-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) and quasi‐RCTs of critically ill people who required fluid volume replacement in hospital or emergency out‐of‐hospital settings. Participants had trauma, burns, or medical conditions such as sepsis. We excluded neonates, elective surgery and caesarean section. We compared a colloid (suspended in any crystalloid solution) versus a crystalloid (isotonic or hypertonic). </p> </section> <section id="CD000567-sec-0005"> <h3 class="title" id="CD000567-sec-0005">Data collection and analysis</h3> <p>Independently, two review authors assessed studies for inclusion, extracted data, assessed risk of bias, and synthesised findings. We assessed the certainty of evidence with GRADE. </p> </section> <section id="CD000567-sec-0006"> <h3 class="title" id="CD000567-sec-0006">Main results</h3> <p>We included 69 studies (65 RCTs, 4 quasi‐RCTs) with 30,020 participants. Twenty‐eight studied starch solutions, 20 dextrans, seven gelatins, and 22 albumin or fresh frozen plasma (FFP); each type of colloid was compared to crystalloids. </p> <p>Participants had a range of conditions typical of critical illness. Ten studies were in out‐of‐hospital settings. We noted risk of selection bias in some studies, and, as most studies were not prospectively registered, risk of selective outcome reporting. Fourteen studies included participants in the crystalloid group who received or may have received colloids, which might have influenced results. </p> <p>We compared four types of colloid (i.e. starches; dextrans; gelatins; and albumin or FFP) versus crystalloids. </p> <p><b>Starches versus crystalloids</b> </p> <p>We found moderate‐certainty evidence that there is probably little or no difference between using starches or crystalloids in mortality at: end of follow‐up (risk ratio (RR) 0.97, 95% confidence interval (CI) 0.86 to 1.09; 11,177 participants; 24 studies); within 90 days (RR 1.01, 95% CI 0.90 to 1.14; 10,415 participants; 15 studies); or within 30 days (RR 0.99, 95% CI 0.90 to 1.09; 10,135 participants; 11 studies). </p> <p>We found moderate‐certainty evidence that starches probably slightly increase the need for blood transfusion (RR 1.19, 95% CI 1.02 to 1.39; 1917 participants; 8 studies), and RRT (RR 1.30, 95% CI 1.14 to 1.48; 8527 participants; 9 studies). Very low‐certainty evidence means we are uncertain whether either fluid affected adverse events: we found little or no difference in allergic reactions (RR 2.59, 95% CI 0.27 to 24.91; 7757 participants; 3 studies), fewer incidences of itching with crystalloids (RR 1.38, 95% CI 1.05 to 1.82; 6946 participants; 2 studies), and fewer incidences of rashes with crystalloids (RR 1.61, 95% CI 0.90 to 2.89; 7007 participants; 2 studies). </p> <p><b>Dextrans versus crystalloids</b> </p> <p>We found moderate‐certainty evidence that there is probably little or no difference between using dextrans or crystalloids in mortality at: end of follow‐up (RR 0.99, 95% CI 0.88 to 1.11; 4736 participants; 19 studies); or within 90 days or 30 days (RR 0.99, 95% CI 0.87 to 1.12; 3353 participants; 10 studies). We are uncertain whether dextrans or crystalloids reduce the need for blood transfusion, as we found little or no difference in blood transfusions (RR 0.92, 95% CI 0.77 to 1.10; 1272 participants, 3 studies; very low‐certainty evidence). We found little or no difference in allergic reactions (RR 6.00, 95% CI 0.25 to 144.93; 739 participants; 4 studies; very low‐certainty evidence). No studies measured RRT. </p> <p><b>Gelatins versus crystalloids</b> </p> <p>We found low‐certainty evidence that there may be little or no difference between gelatins or crystalloids in mortality: at end of follow‐up (RR 0.89, 95% CI 0.74 to 1.08; 1698 participants; 6 studies); within 90 days (RR 0.89, 95% CI 0.73 to 1.09; 1388 participants; 1 study); or within 30 days (RR 0.92, 95% CI 0.74 to 1.16; 1388 participants; 1 study). Evidence for blood transfusion was very low certainty (3 studies), with a low event rate or data not reported by intervention. Data for RRT were not reported separately for gelatins (1 study). We found little or no difference between groups in allergic reactions (very low‐certainty evidence). </p> <p><b>Albumin or FFP versus crystalloids</b> </p> <p>We found moderate‐certainty evidence that there is probably little or no difference between using albumin or FFP or using crystalloids in mortality at: end of follow‐up (RR 0.98, 95% CI 0.92 to 1.06; 13,047 participants; 20 studies); within 90 days (RR 0.98, 95% CI 0.92 to 1.04; 12,492 participants; 10 studies); or within 30 days (RR 0.99, 95% CI 0.93 to 1.06; 12,506 participants; 10 studies). We are uncertain whether either fluid type reduces need for blood transfusion (RR 1.31, 95% CI 0.95 to 1.80; 290 participants; 3 studies; very low‐certainty evidence). Using albumin or FFP versus crystalloids may make little or no difference to the need for RRT (RR 1.11, 95% CI 0.96 to 1.27; 3028 participants; 2 studies; very low‐certainty evidence), or in allergic reactions (RR 0.75, 95% CI 0.17 to 3.33; 2097 participants, 1 study; very low‐certainty evidence). </p> </section> <section id="CD000567-sec-0007"> <h3 class="title" id="CD000567-sec-0007">Authors' conclusions</h3> <p>Using starches, dextrans, albumin or FFP (moderate‐certainty evidence), or gelatins (low‐certainty evidence), versus crystalloids probably makes little or no difference to mortality. Starches probably slightly increase the need for blood transfusion and RRT (moderate‐certainty evidence), and albumin or FFP may make little or no difference to the need for renal replacement therapy (low‐certainty evidence). Evidence for blood transfusions for dextrans, and albumin or FFP, is uncertain. Similarly, evidence for adverse events is uncertain. Certainty of evidence may improve with inclusion of three ongoing studies and seven studies awaiting classification, in future updates. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000567-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000567-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD000567-abs-0008">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD000567-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000567-abs-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000567-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD000567-abs-0016">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD000567-abs-0012">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000567-abs-0020">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD000567-abs-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD000567-abs-0010">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD000567-abs-0009">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000567-abs-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD000567-abs-0015">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000567-abs-0006" lang="en"> <h3>Colloids or crystalloids for fluid replacement in critically people</h3> <p><b>Background</b> </p> <p>Critically ill people may lose large amounts of blood (because of trauma or burns), or have serious conditions or infections (e.g. sepsis); they require additional fluids urgently to prevent dehydration or kidney failure. Colloids and crystalloids are types of fluids that are used for fluid replacement, often intravenously (via a tube straight into the blood). </p> <p>Crystalloids are low‐cost salt solutions (e.g. saline) with small molecules, which can move around easily when injected into the body. </p> <p>Colloids can be man‐made (e.g. starches, dextrans, or gelatins), or naturally occurring (e.g. albumin or fresh frozen plasma (FFP)), and have bigger molecules, so stay in the blood for longer before passing to other parts of the body. Colloids are more expensive than crystalloids. We are uncertain whether they are better than crystalloids at reducing death, need for blood transfusion or need for renal replacement therapy (filtering the blood, with or without dialysis machines, if kidneys fail) when given to critically ill people who need fluid replacement. </p> <p><b>Study characteristics</b> </p> <p>The evidence is current to February 2018. We searched the medical literature and identified 69 relevant studies with 30,020 critically ill participants who were given fluid replacement in hospital or in an emergency out‐of‐hospital setting. Studies compared colloids (starches; dextrans; gelatins; or albumin or FFP) with crystalloids. </p> <p><b>Key results</b> </p> <p>We found moderate‐certainty evidence that using colloids (starches; dextrans; or albumin or FFP) compared to crystalloids for fluid replacement probably makes little or no difference to the number of critically ill people who die within 30 or 90 days, or by the end of study follow‐up. We also found low‐certainty evidence that using gelatins or crystalloids may make little or no difference to the number of deaths within each of these time points. </p> <p>We found moderate‐certainty evidence that using starches probably slightly increases the need for blood transfusion. However, we are uncertain whether using other types of colloids, compared to crystalloids, makes a difference to whether people need a blood transfusion because the certainty of the evidence is very low. </p> <p>We found moderate‐certainty evidence that using starches for fluid replacement probably slightly increases the need for renal replacement therapy. Using albumin or FFP compared to crystalloids may make little or no difference to the need for renal replacement therapy. One study comparing gelatins did not report results for renal replacement therapy according to the type of fluid given, and no studies comparing dextrans assessed renal replacement therapy. </p> <p>Few studies reported adverse events (specifically, allergic reactions, itching, or rashes), so we are uncertain whether either fluid type causes fewer adverse events (very low‐certainty evidence). We found little or no difference between starches or crystalloids in allergic reactions, but fewer participants given crystalloids reported itching or rashes. We found little or no difference in allergic reactions for the use of dextrans (four studies), gelatins (one study), and albumin or FFP (one study). </p> <p><b>Certainty of the evidence</b> </p> <p>Some study authors did not report study methods clearly and many did not register their studies before they started, so we could not be certain whether the study outcomes were decided before or after they saw the results. Also, we found that some people who were given crystalloids may also have had colloids, which might have affected the results. For some outcomes, we had very few studies, which reduced our confidence in the evidence. </p> <p><b>Conclusions</b> </p> <p>Using colloids (starches; dextrans; or albumin or FFP) compared to crystalloids for fluid replacement probably makes little or no difference to the number of critically ill people who die. It may make little or no difference to the number of people who die if gelatins or crystalloids are used for fluid replacement. </p> <p>Starches probably increase the need for blood transfusion and renal replacement therapy slightly. Using albumin or FFP may make little or no difference to the need for renal replacement therapy. We are uncertain whether using dextrans, albumin or FFP, or crystalloids affects the need for blood transfusion. Similarly, we are uncertain if colloids or crystalloids increase the number of adverse events. Results from ongoing studies may increase our confidence in the evidence in future. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000567-sec-0152" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000567-sec-0152">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000567-sec-0214">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000567-sec-0152"></div> <h3 class="title" id="CD000567-sec-0153">Implications for practice</h3> <section id="CD000567-sec-0153"> <p>We found moderate‐certainty evidence that there is probably little or no difference in all‐cause mortality at the end of follow‐up, at 90 days, or at 30 days, between using colloids (starches; dextrans; or albumin or FFP) or crystalloids for fluid resuscitation in critically ill people. We found low‐certainty evidence that there may be little or no difference in all‐cause mortality at these time points between gelatins or crystalloids for fluid resuscitation. Our evidence for all‐cause mortality at the end of follow‐up came from 24 studies of starch solutions, 19 studies of dextrans, six studies of gelatins, and 20 studies of albumin or FFP. </p> <p>However, we found moderate‐certainty evidence of a slight increase in the need for blood transfusion or renal replacement therapy when starches were used for fluid resuscitation. Whilst evidence for adverse events was very low because most studies did not report these events, we found no evidence of a difference in allergic reactions with starches from three studies, and two studies reported more incidences of itching and rashes when starches were used. </p> <p>For other colloid solutions, we found little or no difference in the need for blood transfusion for dextrans, gelatins, or for albumin or FFP versus crystalloids but this was very low‐certainty evidence. We found low‐certainty evidence from two studies that albumin or FFP versus crystalloids may make little or no difference to the need for renal replacement therapy. Similarly, evidence for adverse events for dextrans, gelatins, or albumin or FFP was limited to few studies and was very low certainty: we found little or no difference in allergic reactions between dextrans, gelatins, or albumin or FFP compared to crystalloids. </p> <p>The previous version of this review found that starches might increase mortality, and therefore, differs from the conclusion of this review. However, evidence for this new 2018 version of the review does not include participants who were undergoing elective surgical procedures. </p> </section> <h3 class="title" id="CD000567-sec-0154">Implications for research</h3> <section id="CD000567-sec-0154"> <p>Whilst this review included a large body of evidence reporting outcome data for mortality, we found that few studies reported the number of participants that required transfusion of blood products, required renal replacement therapy, or experienced other adverse events (allergic reactions, itching, and rashes). Consequently, certainty in our evidence for some comparative colloids was limited because of few studies. We found three ongoing studies, and seven studies awaiting classification (of which three are completed studies without published reports). Inclusion of these studies in future updates may contribute additional evidence to the review. </p> <p>We would advise future studies of fluid resuscitation of colloids versus crystalloids to consider blood transfusion and renal replacement therapy as relevant outcomes for consideration, and to provide comprehensive reporting of possible adverse events. We would also advise that studies are managed to avoid the risk of additional colloid solutions being given to some participants in the crystalloids study arm. Improved reporting of suspension solutions when colloids are given would allow for beneficial subgroup analysis for the potential effect of isotonic or hypertonic crystalloids. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000567-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000567-sec-0036"></div> <div class="table" id="CD000567-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Starches compared to crystalloid for fluid resuscitation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Starches compared to crystalloid for fluid resuscitation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> critically ill people requiring fluid resuscitation<br/> <b>Setting:</b> in hospital, in Algeria, Argentina, Belgium, Brazil, Canada, China, France, Germany, India, the Netherlands, Phillipines, South Africa, Switzerland, Tunisia, the UK, USA and Vietnam<br/> <b>Intervention:</b> starches to include hydroxyethyl starch, hetastarch, and pentastarch<br/> <b>Comparison:</b> crystalloids to include normal saline, hypertonic saline, Ringer's lactate and Ringer's acetate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with crystalloids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with starches</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (at end of follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.97<br/> (0.86 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>11,177<br/> (24 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>We excluded data from 1 study because we could not be certain whether it accounted for attrition </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>233 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>226 per 1000<br/> (201 to 254) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (at 90 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.01<br/> (0.90 to 1.14) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>10,415<br/> (15 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>We excluded data from 1 study because we could not be certain whether it accounted for attrition </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>238 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>241 per 1000<br/> (214 to 272) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All‐cause mortality (within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/> (0.90 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>10,135<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We excluded data from 1 study because we could not be certain whether it accounted for attrition </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>191 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000<br/> (172 to 208) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Transfusion of blood products</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.19<br/> (1.02 to 1.39) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1917<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only starches; we noted little or no difference between groups in need for transfusion of blood products in this study </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>299 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>356 per 1000<br/> (305 to 416) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Renal replacement therapy</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.30<br/> (1.14 to 1.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8527<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only starches; we noted little or no difference between groups in need for renal replacement therapy in this study </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>106 per 1000<br/> (93 to 121) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="9" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Allergic reaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="9" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="9" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 2.59 (0.27 to 24.91)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>7757 (3 studies)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Itching</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.38 (1.05 to 1.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>6946 (2 studies)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>26 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>35 per 1000</p> <p>(27 to 46)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Rashes</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.61 (0.90 to 2.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>7007 (2 studies)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>5 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>9 per 1000</p> <p>(5 to 15)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI</b> : confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for study limitations; some included studies had unclear risk of selection bias, one small study had a high risk of selection bias, and we were often unable to assess risk of selective reporting bias because many included studies did not have prospective clinical trials registration.<br/> <sup>b</sup>We downgraded by one level for study limitations; some included studies had unclear risk of selection bias, and we were often unable to assess risk of selective reporting bias because many included studies did not have prospective clinical trials registration.<br/> <sup>c</sup>We downgraded by one level for study limitations; some included studies had unclear risk of selection bias, and we were unable to assess risk of selective reporting bias in some studies because they did not have prospective clinical trials registration. We downgraded by two levels for imprecision; few of our included studies reported data for these outcomes. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000567-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dextrans compared to crystalloid for fluid resuscitation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dextrans compared to crystalloid for fluid resuscitation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> critically ill people requiring fluid resuscitation<br/> <b>Setting:</b> in hospital, or out of hospital, in Brazil, Canada, Denmark, Mexico, Sweden, UK, USA and Vietnam<br/> <b>Intervention:</b> dextrans<br/> <b>Comparison:</b> crystalloids to include: normal saline, hypertonic saline, Ringer's lactate, Ringer's acetate, and unspecified types of crystalloids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with crystalloids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with dextrans</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (at end of follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.99<br/> (0.88 to 1.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>4736<br/> (19 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>237 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>235 per 1000<br/> (209 to 263) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (within 90 days and within 30 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.99<br/> (0.87 to 1.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3353<br/> (10 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>258 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>256 per 1000<br/> (225 to 289) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Transfusion of blood products</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.92</p> <p>(0.77 to 1.10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1272</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>332 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>305 per 1000</p> <p>(255 to 365)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Renal replacement therapy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="9" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Allergic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="9" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 6.00</p> <p>(0.25 to 144.93)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>739</p> <p>(4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Itching</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Rashes</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for study limitations; some included studies had unclear risk of selection bias and we were often unable to assess risk of selective reporting bias because many included studies did not have prospective clinical trials registration.<br/> <sup>b</sup>We downgraded by two levels for study limitations; we noted in two studies that some participants were given additional colloids in the crystalloid group, and in one study we could not be certain whether some participants in the crystalloids groups also received up to 2000 mL colloid resuscitation prior to randomisation. In addition, we were unable to assess risk of selective reporting bias because of lack of prospective clinical trials registration in each study. We downgraded by one level for imprecision; evidence was from three studies.<br/> <sup>c</sup>We downgraded by one level for study limitations; one study had an unclear risk of selection bias and we were unable to assess risk of selective outcome reporting bias in all studies. We downgraded by two levels for imprecision because evidence was from few studies with few events. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000567-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Gelatins compared to crystalloid for fluid resuscitation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Gelatins compared to crystalloid for fluid resuscitation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> critically ill people requiring fluid resuscitation<br/> <b>Setting:</b> in hospital, in Algeria, France, Germany, India, South Africa, Taiwan, Tunisia and Vietnam<br/> <b>Intervention:</b> gelatins<br/> <b>Comparison:</b> crystalloids to include normal saline and Ringer's lactate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with crystalloids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with gelatins</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (at end of follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.89<br/> (0.74 to 1.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1698<br/> (6 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝</p> <p>Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>301 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>268 per 1000<br/> (223 to 325) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (within 90 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.89 (0.73 to 1.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1388</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝</p> <p>Low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>334 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>298 per 1000</p> <p>(244 to 364)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All‐cause mortality (within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.92 (0.74 to 1.16)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1388</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>266 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>244 per 1000</p> <p>(197 to 308)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Transfusion of blood products</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 5.89</p> <p>(0.24 to 142.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>167</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>We calculated an effect estimate for one small study, with one event in the gelatin group. </p> <p>1 study reported transfusion of blood products but data were not reported by group.</p> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only gelatins. We noted little or no difference between groups in need for transfusion of blood products </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Renal replacement therapy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only gelatins. We noted little or no difference between groups in need for renal replacement therapy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Allergic reaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p>We calculated an effect estimate for one small study, with five incidences of allergic reactions in the gelatin group </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 21.61 (1.22 to 384.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>167</p> <p>(1 study)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Itching</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Rashes</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for study limitations; risk of selection bias was unclear in some studies, and because we were unable to assess risk of selective outcome reporting bias in some studies. We downgraded by one level for imprecision; evidence was from few studies, and we could not be certain of time points for data collection.<br/> <sup>b</sup>We downgraded by two levels for imprecision; evidence was from a single study.<br/> <sup>c</sup>We downgraded by one level for study limitations; we were unable to assess risk of selective outcome reporting bias due to lack of prospective clinical trials registration, and some participants in the crystalloid groups also received colloids. We downgraded two levels for imprecision; evidence was from a single small study with very few events. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000567-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Albumin and fresh frozen plasma compared to crystalloid for fluid resuscitation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Albumin and fresh frozen plasma compared to crystalloid for fluid resuscitation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> critically ill people requiring fluid resuscitation<br/> <b>Setting:</b> in hospital and out of hospital, in Algeria, Brazil, Canada, France, Germany, Kenya, India, Italy, Tanzania, Tunisia, Uganda and USA<br/> <b>Intervention:</b> albumin and fresh frozen plasma<br/> <b>Comparison:</b> crystalloids to include: normal saline, hypertonic saline, Ringer's lactate, electrolytes, and unspecified types of crystalloids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with crystalloids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with albumin and FFP</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (at end of follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.98<br/> (0.92 to 1.06) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>13,047<br/> (20 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>One study also reported mortality but not by group, and so could not be included in analysis </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>254 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>249 per 1000<br/> (234 to 270) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (within 90 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.98<br/> (0.92 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>12,492<br/> (10 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>One study also reported mortality but not by group, and so could not be included in analysis </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>259 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>254 per 1000<br/> (239 to 270) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All‐cause mortality (within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/> (0.93 to 1.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>12,506<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study also reported mortality but not by group, and so could not be included in analysis </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>234 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>231 per 1000<br/> (217 to 248) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Transfusion of blood products</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.31<br/> (0.95 to 1.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>290<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only albumins or FFP; we noted little or no difference between groups in need for transfusion of blood products </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>281 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>368 per 1000<br/> (267 to 506) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Renal replacement therapy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>201 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>223 per 1000</p> <p>(193 to 255)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.11 (0.96 to 1.27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3028</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p>Low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One study stated that renal replacement data were measured but it was not reported in the study report (abstract) </p> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only albumin and FFP. We noted little or no difference between groups in need for renal replacement therapy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Allergic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.75 (0.17 to 3.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2097</p> <p>(1 study)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>4 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>3 per 1000</p> <p>(1 to 13)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Itching</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Rashes</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>FFP:</b> fresh frozen plasma <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for study limitations; some included studies had unclear risk of selection bias, and we were often unable to assess risk of selective reporting bias because many included studies did not have prospective clinical trials registration.<br/> <sup>b</sup>We downgraded by two levels for study limitations; some studies had unclear risk of selection bias, and we noted baseline imbalances in one study. We downgraded by one level for imprecision because analysis included few studies with few participants.<br/> <sup>c</sup>We downgraded by two levels for study limitations; we noted baseline imbalances and we could not be certain how many participants in the crystalloids group may have received additional colloids.<br/> <sup>d</sup>We downgraded by one level for study limitations; we were unable to assess risk of selective reporting bias because the included study did not appear to have prospective clinical trials registration. We downgraded by two levels for imprecision; evidence was from a single study with few events. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000567-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000567-sec-0037">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000567-sec-0179">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD000567-sec-0037"></div> <section id="CD000567-sec-0038"> <h3 class="title" id="CD000567-sec-0038">Description of the condition</h3> <p>Critically ill people may experience excessive fluid loss, and hypovolaemia, because of haemorrhage from serious injury or burns, or because of critical illnesses, which lead to dehydration, vomiting, or diarrhoea. Fluid loss may lead to mortality and morbidity, for example, haemorrhage accounts for almost half of deaths in the first 24 hours after traumatic injury (<a href="./references#CD000567-bbs2-0121" title="GeeraedtsLMJr , KaasjagerHA , VanVugtAB , FrolkeJP . Exsanguination in trauma: a review of diagnostics and treatment options. Injury2009;40(1):11‐20. [PUBMED: 19135193] ">Geeraedts 2009</a>; <a href="./references#CD000567-bbs2-0132" title="KauvarDS , LeferingR , WadeCE . Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. The Journal of Trauma2006;60(6 Suppl):S3‐11. [PUBMED: 16763478] ">Kauvar 2006</a>), and, worldwide, traumatic injury is a leading cause of death (<a href="./references#CD000567-bbs2-0137" title="PedenM , HyderA . Road traffic injuries are a global public health problem. BMJ2002; Vol. 324, issue 7346:1153. [PUBMED: 12003892] ">Peden 2002</a>). Changes in body fluid balance may also lead to acute kidney injury or failure. </p> </section> <section id="CD000567-sec-0039"> <h3 class="title" id="CD000567-sec-0039">Description of the intervention</h3> <p>Fluid resuscitation is one of the most important strategies for early management of critically ill people (<a href="./references#CD000567-bbs2-0141" title="RhodesA , EvansLE , AlhazzaniW , LevyMM , AntonelliM , FerrerR , et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Critical Care Medicine2016;45(3):486‐552. [PUBMED: 28098591] ">Rhodes 2016</a>; <a href="./references#CD000567-bbs2-0142" title="RossaintR , BouillonB , CernyV , CoatsTJ , DuranteauJ , Fernandez‐MondejarE , et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Critical Care2016;20:100. [PUBMED: 27072503] ">Rossaint 2016</a>). Fluids used for this purpose are crystalloids or colloids. </p> <p>Crystalloids, such as saline and Ringer's lactate, are solutions of salt, water and minerals, and are commonly used in the clinical setting. They have small molecules, and, when used intravenously, they are effective as volume expanders. They may have an isotonic or hypertonic composition, which could affect the distribution of fluid in the body; for example, because hypertonic crystalloids lower plasma osmolality they cause water movement from the intravascular to the extravascular space, and a lower volume may be required for fluid resuscitation (<a href="./references#CD000567-bbs2-0113" title="CoppolaS , FroioS , ChiumelloD . Fluid resuscitation in trauma patients: what should we know?. Current Opinion in Critical Care2014;20(4):444‐50. [PUBMED: 24927043] ">Coppola 2014</a>). They are cheap and easy to use, with few side effects. However, because they move more easily into the extravascular space, their use may increase oedema (<a href="./references#CD000567-bbs2-0113" title="CoppolaS , FroioS , ChiumelloD . Fluid resuscitation in trauma patients: what should we know?. Current Opinion in Critical Care2014;20(4):444‐50. [PUBMED: 24927043] ">Coppola 2014</a>). The composition of the crystalloid may not affect clinical outcomes; recent reviews have examined the possible effect of hypertonic solutions (<a href="./references#CD000567-bbs2-0143" title="ShrumB , ChurchB , McArthurE , BurnsKEA , ZnajdaT , McAlisterV . Hypertonic salt solution for peri‐operative fluid management. Cochrane Database of Systematic Reviews2016, Issue 6. [DOI: 10.1002/14651858.CD005576.pub3] ">Shrum 2016</a>), and compared buffered with non‐buffered fluids (<a href="./references#CD000567-bbs2-0112" title="BampoeS , OdorPM , DushianthanA , Bennett‐GuerreroE , CroS , GanTJ , et al. Perioperative administration of buffered versus non‐buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures. Cochrane Database of Systematic Reviews2017, Issue 9. [DOI: 10.1002/14651858.CD004089.pub3] ">Bampoe 2017</a>), but have not found important clinical differences. </p> <p>Colloids, which are suspended in crystalloid solutions, are similarly given for the purpose of volume expansion. Different types of colloids may be grouped as synthetic or semi‐synthetic, for example: starches, dextrans, gelatins; or naturally occurring, such as human albumin or fresh frozen plasma (FFP). These colloid solutions have different pharmacokinetic properties that may affect plasma expansion in different ways (<a href="./references#CD000567-bbs2-0136" title="Orbegozo CortesD , Gamarano BarrosT , NjimiH , VincentJL . Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta‐regression. Anesthesia and Analgesia2015;120(2):389‐402. [PUBMED: 25565318] ">Orbegozo 2015</a>). All colloids have a larger molecular weight than crystalloids and do not cross the endothelium into the interstitial fluid easily. This means that they stay in the intervascular space for longer than crystalloids, provide the benefit of rapid plasma expansion, and can correct colloidal osmotic pressure (<a href="./references#CD000567-bbs2-0135" title="McClellandDB . Safety of human albumin as a constituent of biologic therapeutic products. Transfusion1998;38(7):690‐9. [PUBMED: 9683109] ">McClelland 1998</a>). Colloids are a more expensive fluid replacement option, and they may have adverse effects such as allergic reactions, blood clotting disorders, and kidney failure (<a href="./references#CD000567-bbs2-0111" title="BaileyAG , McNaullPP , JoosteE , TuchmanJB . Perioperative crystalloid and colloid fluid management in children: where are we and how did we get here?. Anesthesia and Analgesia2010;110(2):375‐90. [PUBMED: 19955503] ">Bailey 2010</a>). </p> </section> <section id="CD000567-sec-0040"> <h3 class="title" id="CD000567-sec-0040">Why it is important to do this review</h3> <p>This is an update of a Cochrane Review that was first published in 1997 and has been updated several times since. The most recent published version of this Cochrane Review looked at the effect of colloids and crystalloids on mortality at the end of study follow‐up (<a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a>). Meta‐analysis demonstrated no evidence of a difference in mortality when participants were given dextrans, gelatins, albumin or FFP, versus crystalloids. However, the review found evidence of an increase in mortality with the use of starches. Whilst some advise against using starches as a first line of resuscitation (<a href="./references#CD000567-bbs2-0139" title="ReinhartK , PernerA , SprungCL , JaeschkeR , SchortgenF , Johan GroeneveldAB , et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Medicine2012;38(3):368‐83. [PUBMED: 22323076] ">Reinhart 2012</a>), this is not consistent with findings from large randomised trials (<a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>), nor with some other systematic reviews (<a href="./references#CD000567-bbs2-0127" title="HeB , XuB , XuX , LiL , RenR , ChenZ , et al. Hydroxyethyl starch versus other fluids for non‐septic patients in the intensive care unit: a meta‐analysis of randomized controlled trials. Critical Care2015;19:92. [PUBMED: 25886952] ">He 2015</a>; <a href="./references#CD000567-bbs2-0138" title="QureshiSH , RizviSI , PatelNN , MurphyGJ . Meta‐analysis of colloids versus crystalloids in critically ill, trauma and surgical patients. The British Journal of Surgery2016;103(1):14‐26. [PUBMED: 26522616] ">Qureshi 2016</a>). </p> <p>It is possible that results from <a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a> could have been confounded by the inclusion of a wider variety of participants in need of fluid resuscitation. In this review, we have sought to reduce heterogeneity in a critically ill population as much as possible by excluding participants who were scheduled for elective surgery; whilst these participants may require fluid replacement during perioperative management to reduce the risk of hypovolaemia, they are less likely to be critically ill at the point of randomisation ‐ even elderly people undergoing semi‐urgent surgery can seldom be seen as critically ill (<a href="./references#CD000567-bbs2-0133" title="LewisSR , ButlerAR , BrammarA , NicholsonA , SmithAF . Perioperative fluid volume optimization following proximal femoral fracture. Cochrane Database of Systematic Reviews2016, Issue 3. [DOI: 10.1002/14651858.CD003004.pub4] ">Lewis 2016</a>). </p> <p>Also, our aim was to explore other effects of colloids or crystalloids on resuscitation. In particular we aimed to consider whether colloids or crystalloids affect the number of people who require blood transfusion, and the effect on renal function by assessing whether more or fewer critically ill people are likely to need renal replacement therapy after fluid resuscitation interventions, because evidence suggests that use of some types of fluids may increase these risks (<a href="./references#CD000567-bbs2-0145" title="ZarychanskiR , Abou‐SettaAM , TurgeonAF , HoustonBL , McIntyreL , MarshallJC , et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta‐analysis. JAMA2013;309(7):678‐88. [PUBMED: 23423413] ">Zarychanski 2013</a>). In addition, we considered the effect of type of fluids on adverse events (allergic reactions, itching or pruritis, and rashes) that have been reported in trials (e.g. in <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000567-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000567-sec-0041">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000567-sec-0183">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000567-sec-0041"></div> <p>To assess the effect of using colloids versus crystalloids in critically ill people requiring fluid volume replacement on mortality, need for blood transfusion or renal replacement therapy, and adverse events (specifically: allergic reactions, itching, rashes). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000567-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000567-sec-0042">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000567-sec-0184">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000567-sec-0042"></div> <section id="CD000567-sec-0043"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000567-sec-0044"> <h4 class="title">Types of studies</h4> <p>We included parallel‐design randomised controlled trials (RCTs), and quasi‐randomised studies (e.g. studies in which the method of assignment is based on alternation, date of birth or medical record number). We excluded randomised cross‐over trials. We excluded study reports that had been retracted after publication. </p> </section> <section id="CD000567-sec-0045"> <h4 class="title">Types of participants</h4> <p>We included participants who required fluid volume replacement in hospital or in an emergency out‐of‐hospital setting. We included participants who were described as critically ill, and participants who required fluid volume replacement as a result of trauma, burns, or medical conditions such as sepsis. </p> <p>We excluded studies of participants undergoing elective surgical procedures. We excluded neonates, and women undergoing caesarean section. </p> <p>See <a href="#CD000567-sec-0173">Differences between protocol and review</a>. </p> </section> <section id="CD000567-sec-0046"> <h4 class="title">Types of interventions</h4> <p>We included studies that compared a colloid (suspended in any crystalloid solution) versus a crystalloid. We excluded studies in which a colloid was given in both groups of participants. </p> <p>We included the following colloids: starches; dextrans; gelatins; albumin or fresh frozen plasma (FFP). We included crystalloids of different electrolyte compositions (isotonic or hypertonic). </p> <p>We considered each colloid type as a separate comparison group. Therefore, we compared:</p> <p> <ul id="CD000567-list-0001"> <li> <p>starches versus crystalloids;</p> </li> <li> <p>dextrans versus crystalloids;</p> </li> <li> <p>gelatins versus crystalloids;</p> </li> <li> <p>albumin or FFP versus crystalloids.</p> </li> </ul> </p> <p>We excluded studies in which the colloid was given to replace a known nutritional deficiency (for example, given for hypoalbuminaemia), or was given as a preloading solution before surgery. We excluded studies in which fluids were given to people with head injury to control intracranial pressure. </p> <p>See <a href="#CD000567-sec-0173">Differences between protocol and review</a>. </p> </section> <section id="CD000567-sec-0047"> <h4 class="title">Types of outcome measures</h4> <p>We did not exclude studies that did not measure or report review outcomes.</p> <p>We collected outcome data for mortality from any cause at end‐of‐study follow‐up; we included data for this outcome for which the time point was not reported, and for which the time point was reported as 'before hospital discharge', 'within the ICU', or within 30 days, 60 days, or 90 days. In addition, we collected mortality data that were clearly reported within 90 days, or within 30 days. Our secondary outcomes assessed the effectiveness of the resuscitation fluids and included need for transfusion of any blood product, and need for renal replacement therapy. In addition, we collected data for outcomes of adverse events, specifically: allergic reactions, itching/pruritis, and rashes. </p> <section id="CD000567-sec-0048"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD000567-list-0002"> <li> <p>All‐cause mortality (at end of follow‐up)</p> </li> <li> <p>All‐cause mortality (within 90 days)</p> </li> <li> <p>All‐cause mortality (within 30 days)</p> </li> </ul> </p> </section> <section id="CD000567-sec-0049"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD000567-list-0003"> <li> <p>Transfusion of blood products</p> </li> <li> <p>Renal replacement therapy</p> </li> <li> <p>Adverse events (allergic reactions, itching, and rashes)</p> </li> </ul> </p> </section> </section> </section> <section id="CD000567-sec-0050"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD000567-sec-0051"> <h4 class="title">Electronic searches</h4> <p>We developed subject‐specific search strategies in consultation with the Cochrane Injuries Group Information Specialist. We identified RCTs through literature searching of the following electronic databases: </p> <p> <ul id="CD000567-list-0004"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 2) (which contains the Cochrane Injuries Trials Register) in the Cochrane Library (searched 23 February 2018) (<a href="./appendices#CD000567-sec-0158">Appendix 1</a>); </p> </li> <li> <p>MEDLINE Ovid (1946 to 23 February 2018) (<a href="./appendices#CD000567-sec-0159">Appendix 2</a>); </p> </li> <li> <p>Embase Ovid (1974 to 23 February 2018) (<a href="./appendices#CD000567-sec-0160">Appendix 3</a>); </p> </li> <li> <p>PubMed (1948 to 23 February 2018) (<a href="./appendices#CD000567-sec-0161">Appendix 4</a>); </p> </li> <li> <p>Web of Science (Core Collection, 1970 to 23 February 2018) (<a href="./appendices#CD000567-sec-0162">Appendix 5</a>); </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 13 April 2018) (<a href="./appendices#CD000567-sec-0163">Appendix 6</a>); </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>; searched 13 April 2018) (<a href="./appendices#CD000567-sec-0164">Appendix 7</a>) </p> </li> <li> <p>OpenGrey (System for Information on Grey Literature in Europe) (<a href="http://www.opengrey.eu" target="_blank">www.opengrey.eu</a>; searched 12 April 2018) (<a href="./appendices#CD000567-sec-0165">Appendix 8</a>). </p> </li> </ul> </p> <p>This review was an update of a previous Cochrane Review (<a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a>). However, because we made changes to the inclusion criteria and increased the outcome measures, we ran all the searches from database inception. </p> </section> <section id="CD000567-sec-0052"> <h4 class="title">Searching other resources</h4> <p>We conducted citation searching of identified included studies published from 2013 onwards in Web of Science (<a href="http://apps.webofknowledge.com" target="_blank">apps.webofknowledge.com</a>) (12 April 2018). We scanned reference lists of relevant systematic reviews (identified during database searches) to search for additional trials. </p> </section> </section> <section id="CD000567-sec-0053"> <h3 class="title" id="CD000567-sec-0053">Data collection and analysis</h3> <p>Two review authors (Sharon Lewis (SL) and either: Michael Pritchard (MP), Andrew Butler (AB), or David Evans (DE)) independently completed all data collection and analyses before comparing results and reaching consensus. We consulted a third review author (Andrew Smith (AS)) to resolve conflicts if necessary. </p> <section id="CD000567-sec-0054"> <h4 class="title">Selection of studies</h4> <p>We used <a href="./references#CD000567-bbs2-0119" title="Thomson Reuters. Endnote X5. Philadelphia (PA): Thomson Reuters, 2011. ">Endnote</a> reference management software to collate the results of the searches and to remove duplicates. We used <a href="./references#CD000567-bbs2-0114" title="Veritas Health Innovation. Covidence. Melbourne (Australia): Veritas Health Innovation, (accessed 23 February 2018). ">Covidence</a> software to screen titles and abstracts and identify potentially relevant studies. We sourced the full texts of all potentially relevant studies and assessed whether the studies met the review inclusion criteria (see <a href="#CD000567-sec-0043">Criteria for considering studies for this review</a>). We reviewed abstracts at this stage and included these in the review only if they provided sufficient information to assess eligibility. </p> <p>We reassessed eligibility of studies included in the last version of the review (<a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a>), because of changes made to review inclusion criteria. </p> <p>We recorded the number of papers retrieved at each stage and reported this in a PRISMA flow chart (<a href="./references#CD000567-bbs2-0134" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GotzschePC , IoannidisJP , et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology2009;62(10):e1‐34. [PUBMED: 19631507] ">Liberati 2009</a>; <a href="#CD000567-fig-0001">Figure 1</a>). We reported in the review brief details of closely related but excluded papers. </p> <div class="figure" id="CD000567-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD000567-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD000567-sec-0055"> <h4 class="title">Data extraction and management</h4> <p>We used <a href="./references#CD000567-bbs2-0114" title="Veritas Health Innovation. Covidence. Melbourne (Australia): Veritas Health Innovation, (accessed 23 February 2018). ">Covidence</a> software to extract data from individual studies. A basic template for data extraction forms is available at <a href="http://www.covidence.org" target="_blank">www.covidence.org</a>. We adapted this template to include the following information. </p> <p> <ul id="CD000567-list-0005"> <li> <p>Methods ‐ type of study design; setting; country; dates of study; funding sources</p> </li> <li> <p>Participants ‐ number of participants randomised to each group, number of lost participants, and number of analysed participants, participant condition or reason for fluid resuscitation. Baseline characteristics to include: age, gender, weight or body mass index, blood pressure, prognostic or illness severity scores (American Society of Anaesthesiologists (ASA), Acute Physiology and Chronic Health Evaluation (APACHE) I or II, Simplified Acute Physiology Score (SAPS), Sequential Organ Failure Assessment (SOFA), Glasgow Coma Scale (GCS)) </p> </li> <li> <p>Interventions ‐ details of colloid and crystalloid (concentration of solution, volume, and rate of administration), additional relevant patient management </p> </li> <li> <p>Outcomes ‐ all outcomes reported by study authors, relevant outcomes (including time of measurement for mortality) </p> </li> <li> <p>Outcome data ‐ results of outcome data</p> </li> </ul> </p> <p>Because of changes in reporting expectations in Cochrane Reviews ‐ the Methodological Expectations of Cochrane Intervention Reviews (MECIR) (<a href="./references#CD000567-bbs2-0130" title="HigginsJP , LassersonT , ChandlerJ , ToveyD , ChurchillR . Methodological Expectations of Cochrane Intervention Reviews. Cochrane: London, Version 1.02, 2016. Available from community.cochrane.org/sites/default/files/uploads/MECIR%20PRINTED%20BOOKLET%20FINAL%20v1.02.pdf. ">Higgins 2016</a>) ‐ since the last version of the review (<a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a>), we also used <a href="./references#CD000567-bbs2-0114" title="Veritas Health Innovation. Covidence. Melbourne (Australia): Veritas Health Innovation, (accessed 23 February 2018). ">Covidence</a> to re‐conduct data extraction on studies included in the last version of the review. </p> <p>We considered the applicability of information from individual studies and the generalisability of data to our intended study population (i.e. the potential for indirectness in the review). If we found associated publications from the same study, we created a composite data set based on all eligible publications. </p> </section> <section id="CD000567-sec-0056"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (SL and MP, AB, or DE) independently assessed study quality, study limitations, and the extent of potential bias using the Cochrane 'Risk of bias' tool (<a href="./references#CD000567-bbs2-0131" title="HigginsJP , AltmanDG , SterneJA , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>). We completed 'Risk of bias' assessment only for studies that reported the review outcomes. </p> <p>We assessed the following domains.</p> <p> <ul id="CD000567-list-0006"> <li> <p>Sequence generation (selection bias)</p> </li> <li> <p>Allocation concealment (selection bias)</p> </li> <li> <p>Blinding of participants, personnel, and outcome assessors (performance bias and detection bias) </p> </li> <li> <p>Incomplete outcome data (attrition bias)</p> </li> <li> <p>Selective outcome reporting (reporting bias)</p> </li> <li> <p>Baseline characteristics</p> </li> <li> <p>Other bias</p> </li> </ul> </p> <p>We made separate judgements for performance and detection bias for mortality and for blood transfusion/renal replacement therapy/adverse events. </p> <p>For each domain, we judged whether study authors had made sufficient attempts to minimise bias in their study design. We made judgements using three measures, high, low and unclear risk of bias. We recorded this decision in 'Risk of bias' tables and present a 'Risk of bias' graph and summary figure (<a href="#CD000567-fig-0002">Figure 2</a>; <a href="#CD000567-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD000567-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. We did not make judgements for studies that did not report outcomes of interest in the review, which are indicated by blank spaces" data-id="CD000567-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. We did not make judgements for studies that did not report outcomes of interest in the review, which are indicated by blank spaces </p> </div> </div> </div> <div class="figure" id="CD000567-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study. We did not make judgements for studies that did not report outcomes of interest in the review, which are indicated by blank spaces" data-id="CD000567-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. We did not make judgements for studies that did not report outcomes of interest in the review, which are indicated by blank spaces </p> </div> </div> </div> <p>Because of changes in reporting expectations in Cochrane Reviews (MECIR; <a href="./references#CD000567-bbs2-0130" title="HigginsJP , LassersonT , ChandlerJ , ToveyD , ChurchillR . Methodological Expectations of Cochrane Intervention Reviews. Cochrane: London, Version 1.02, 2016. Available from community.cochrane.org/sites/default/files/uploads/MECIR%20PRINTED%20BOOKLET%20FINAL%20v1.02.pdf. ">Higgins 2016</a>) since the last version of the review, we also completed a 'Risk of bias' assessment on all studies included in <a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a>. </p> </section> <section id="CD000567-sec-0057"> <h4 class="title">Measures of treatment effect</h4> <p>We collected dichotomous data for each outcome measure (the number of participants who had died, the number of participants who required transfusion of blood products, the number of participants who required renal replacement therapy, and the number of participants who had adverse events). </p> </section> <section id="CD000567-sec-0058"> <h4 class="title">Unit of analysis issues</h4> <p>We reported data separately according to type of colloid (starches; dextrans; gelatins; albumin or FFP). </p> <p>For multi‐arm studies that included more than one of the same type of study fluid (e.g. two groups of starches combined with an isotonic or a hypertonic crystalloid), we combined data from study groups in the same analysis only when it was appropriate and when it did not include double‐counting of participants. </p> <p>In subgroup analysis, in which studies were grouped by different types of crystalloid solution, it was not always appropriate to combine data from multi‐arm study groups. If we had included multi‐arm studies in subgroup analysis, we planned to use the halving method to avoid unit of analysis issues (<a href="./references#CD000567-bbs2-0116" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses.In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). </p> </section> <section id="CD000567-sec-0059"> <h4 class="title">Dealing with missing data</h4> <p>We assessed whether all measured outcomes had been reported by study authors by comparing, when possible, published reports with protocols or clinical trials register documents that had been prospectively published. </p> <p>We assessed whether all randomised participants had been included in outcome data. In the absence of an explanation for loss of data, we used the 'Risk of bias' tool to judge whether a study was at high risk of attrition bias. </p> </section> <section id="CD000567-sec-0060"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed whether evidence of inconsistency was apparent in our results by considering heterogeneity. We assessed clinical and methodological heterogeneity by comparing similarities in our included studies between study designs, participants, and interventions, using data collected during data extraction (<a href="#CD000567-sec-0055">Data extraction and management</a>). We assessed statistical heterogeneity by calculating the Chi² test and I² statistic (<a href="./references#CD000567-bbs2-0128" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>), and judged any heterogeneity using values of I² greater than 60% and Chi² P value of 0.05 or less to indicate moderate to substantial statistical heterogeneity (<a href="./references#CD000567-bbs2-0116" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses.In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). </p> <p>As well as looking at statistical results, we considered point estimates and overlap of confidence intervals (CIs). If CIs overlap, then results are more consistent. Combined studies may show a large consistent effect but with significant heterogeneity. Therefore, we planned to interpret heterogeneity with caution (<a href="./references#CD000567-bbs2-0124" title="GuyattGH , OxmanAD , KunzR , WoodcockJ , BrozekJ , HelfandM , et al. GRADE guidelines: 7. Rating the quality of evidence ‐ inconsistency. Journal of Clinical Epidemiology2011;64(12):1294‐302. [PUBMED: 21803546] ">Guyatt 2011a</a>). </p> </section> <section id="CD000567-sec-0061"> <h4 class="title">Assessment of reporting biases</h4> <p>We attempted to source published protocols for each of our included studies by using clinical trials registers. We compared protocols or clinical trials register documents that had been prospectively published with study results to assess the risk of selective reporting. We generated a funnel plot to assess risk of publication bias in the review, for outcomes in which we identified more than 10 studies (<a href="./references#CD000567-bbs2-0144" title="SterneJA , EggerM , MoherD , BoutronI , editor(s) . Chapter 10: Addressing reporting biases. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook. ">Sterne 2017</a>). An asymmetrical funnel plot may suggest publication of only positive results (<a href="./references#CD000567-bbs2-0117" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.)1997;315(7109):629‐34. [PUBMED: 9310563] ">Egger 1997</a>). We included funnel plot figures for the primary outcome: all‐cause mortality (at the end of follow‐up) (<a href="#CD000567-fig-0004">Figure 4</a>; <a href="#CD000567-fig-0005">Figure 5</a>; <a href="#CD000567-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD000567-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison 1. Starches vs crystalloid, outcome: 1.1 mortality at end of follow‐up" data-id="CD000567-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison 1. Starches vs crystalloid, outcome: 1.1 mortality at end of follow‐up </p> </div> </div> </div> <div class="figure" id="CD000567-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison 2. Dextrans vs crystalloid, outcome: 2.1 mortality at end of follow‐up" data-id="CD000567-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison 2. Dextrans vs crystalloid, outcome: 2.1 mortality at end of follow‐up </p> </div> </div> </div> <div class="figure" id="CD000567-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison 4. Albumin and FFP vs crystalloid, outcome: 4.1 mortality at end of follow‐up" data-id="CD000567-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison 4. Albumin and FFP vs crystalloid, outcome: 4.1 mortality at end of follow‐up </p> </div> </div> </div> </section> <section id="CD000567-sec-0062"> <h4 class="title">Data synthesis</h4> <p>We completed meta‐analysis of outcomes in which we had comparable effect measures for more than one study, and when measures of clinical and methodological heterogeneity indicated that pooling was appropriate. </p> <p>We presented results according to type of colloid (starches; dextrans; gelatins; albumin or FFP) as four separate comparisons (see <a href="#CD000567-sec-0046">Types of interventions</a>). </p> <p>We used the statistical calculator in Review Manager 5 (RevMan 5) to calculate risk ratios (RR) using the Mantel‐Haenszel model (<a href="./references#CD000567-bbs2-0140" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We used a random‐effects statistical model that accounted for the variation amongst participant groups in the review. We calculated CIs at 95% and used a P value of 0.05 or less to judge whether a result was statistically significant. We considered imprecision in the results of analyses by assessing the CI around an effect measure; a wide CI would suggest a higher level of imprecision in our results. A small number of identified studies may also reduce precision (<a href="./references#CD000567-bbs2-0125" title="GuyattGH , OxmanAD , KunzR , BrozekJ , Alonso‐CoelloP , RindD , et al. GRADE guidelines 6. Rating the quality of evidence ‐ imprecision. Journal of Clinical Epidemiology2011;64(12):1283‐93. [PUBMED: 21839614] ">Guyatt 2011b</a>). </p> </section> <section id="CD000567-sec-0063"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We explored potential differences in the tonicity of crystalloid solutions that had been used with colloids or used as the comparative crystalloid. This was an a priori subgroup analysis included in the previous version of the review (<a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a>). We used the calculator in RevMan 5 to perform subgroup analysis, comparing the Chi² and P value for the test for subgroup differences; we interpreted a P value of less than 0.05 as being indicative of a difference between subgroups. We conducted subgroup analysis when data were available for more than 10 studies (<a href="./references#CD000567-bbs2-0116" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses.In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). We considered subgroup analysis only for the primary outcome (all‐cause mortality (at end of follow‐up)) for each of our comparisons (starches; dextrans; gelatins; albumin or FFP). Subgroups were as follows. </p> <p> <ul id="CD000567-list-0007"> <li> <p>Tonicity of crystalloid solution:</p> <ul id="CD000567-list-0008"> <li> <p>colloid + isotonic crystalloid versus isotonic crystalloid;</p> </li> <li> <p>colloid + hypertonic crystalloid versus isotonic crystalloid;</p> </li> <li> <p>colloid + isotonic crystalloid versus hypertonic crystalloid;</p> </li> <li> <p>colloid + hypertonic crystalloid versus hypertonic crystalloid.</p> </li> </ul> </li> </ul> </p> </section> <section id="CD000567-sec-0064"> <h4 class="title">Sensitivity analysis</h4> <p>We explored the potential effects of decisions made as part of the review process as follows. </p> <p> <ul id="CD000567-list-0009"> <li> <p>We excluded all studies that we judged to be at high or unclear risk of selection bias. </p> </li> <li> <p>We excluded studies in which we noted that some participants in the crystalloid group were given, or may have been given, additional colloids. </p> </li> <li> <p>We conducted meta‐analysis using the alternative meta‐analytical effects model (fixed‐effect).</p> </li> <li> <p>We used alternative data for individual studies in which we noted discrepancies in reported data. </p> </li> </ul> </p> <p>We conducted sensitivity analysis on the primary outcome: all‐cause mortality (at end of follow‐up). </p> <section id="CD000567-sec-0065"> <h5 class="title">'Summary of findings' table and GRADE</h5> <p>We used the GRADE system to assess the certainty of the body of evidence associated with the following outcomes (<a href="./references#CD000567-bbs2-0123" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians?. BMJ (Clinical Research Ed.)2008;336(7651):995‐8. [PUBMED: 18456631] '>Guyatt 2008</a>). </p> <p> <ul id="CD000567-list-0010"> <li> <p>All‐cause mortality (at end of follow‐up)</p> </li> <li> <p>All‐cause mortality (within 90 days)</p> </li> <li> <p>All‐cause mortality (within 30 days)</p> </li> <li> <p>Transfusion of blood products</p> </li> <li> <p>Renal replacement therapy</p> </li> <li> <p>Adverse events (allergic reactions, itching, rashes)</p> </li> </ul> </p> <p>The GRADE approach appraises the certainty of a body of evidence based on the extent to which one can be confident that an estimate of effect or association reflects the item being assessed. Evaluation of the certainty of a body of evidence considers within‐study risk of bias, directness of the evidence, heterogeneity of the data, precision of effect estimates, and risk of publication bias. </p> <p>We constructed four 'Summary of findings' tables using the GRADEpro GDT software to create 'Summary of findings' tables for the following comparisons in this review (<a href="./references#CD000567-bbs2-0122" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 23 February 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>). </p> <p> <ul id="CD000567-list-0011"> <li> <p>Starches versus crystalloids</p> </li> <li> <p>Dextrans versus crystalloids</p> </li> <li> <p>Gelatins versus crystalloids</p> </li> <li> <p>Albumin or FFP versus crystalloids</p> </li> </ul> </p> <p>One review author (SL) completed the table in consultation with a second author (MP).</p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000567-sec-0066" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000567-sec-0066"></div> <section id="CD000567-sec-0067"> <h3 class="title">Description of studies</h3> <section id="CD000567-sec-0068"> <h4 class="title">Results of the search</h4> <p>We screened 7920 titles and abstracts from database searches, forward and backward citation searches, and clinical trials register searches. We assessed 248 full‐text reports for eligibility. See <a href="#CD000567-fig-0001">Figure 1</a>. </p> </section> <section id="CD000567-sec-0069"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD000567-sec-0175" title="">Characteristics of included studies</a>. </p> <p>We included 69 studies; 42 of these had been included in the previous version of the review (<a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a>), and 27 were included for the first time in this update. </p> <p>These 69 studies comprised a total of 114 publications, and included 30,020 participants (<a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0005" title="BentsenG , BreivikH , LundarT , StubhaugA . Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo‐controlled study involving stable patients with subarachnoid hemorrhage. Critical Care Medicine2006;34(12):2912‐7. [17075367] ">Bentsen 2006</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0017" title="ErnestD , BelzbergAS , DodekPM . Distribution of normal saline and 5% albumin infusions in septic patients. Critical Care Medicine1999;27(1):46‐50. [PUBMED: 9934892] ">Ernest 1999</a>; <a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0021" title="Grba‐BujevicM , Bosan‐KilibardaI , StrikicN . The use of hypertonic‐hyperoncotic solution for hypovolemic shock in trauma patients in prehospital setting. Neurologia Croatica2012;61(Suppl 2):21‐4. ">Grba‐Bujevic 2012</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0037" title="MasoumiK , ForouzanA , DarianAA , Rafaty NavaiiA . Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. Journal of Clinical Medicine Research2016;8(11):815‐8. [PUBMED: 27738483] ">Masoumi 2016</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>; <a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>). </p> <p>Four studies were quasi‐randomised (<a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>), and the remaining studies were RCTs. </p> <p>We included three studies for which we could only source the abstract (<a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>); we sourced the full text of all remaining studies. </p> <section id="CD000567-sec-0070"> <h5 class="title">Study population</h5> <p>Participants had a wide variety of diagnoses for which fluid volume resuscitation was required, including: trauma, burns, and medical conditions such as sepsis and hypovolaemic shock. We have listed each study with the primary participant conditions in <a href="#CD000567-tbl-0005">Table 1</a>. </p> <div class="table" id="CD000567-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of participant conditions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participant condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Admission to an ICU with any condition (which included trauma, sepsis, ARDS, head injury) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trauma (includes studies of 'any trauma admissions', and head, chest, and abdominal injuries, and trauma with haemorrhagic or hypovolaemic shock) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>*; <a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0021" title="Grba‐BujevicM , Bosan‐KilibardaI , StrikicN . The use of hypertonic‐hyperoncotic solution for hypovolemic shock in trauma patients in prehospital setting. Neurologia Croatica2012;61(Suppl 2):21‐4. ">Grba‐Bujevic 2012</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0037" title="MasoumiK , ForouzanA , DarianAA , Rafaty NavaiiA . Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. Journal of Clinical Medicine Research2016;8(11):815‐8. [PUBMED: 27738483] ">Masoumi 2016</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sepsis or septic shock</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>*; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0017" title="ErnestD , BelzbergAS , DodekPM . Distribution of normal saline and 5% albumin infusions in septic patients. Critical Care Medicine1999;27(1):46‐50. [PUBMED: 9934892] ">Ernest 1999</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a> (cancer with sepsis); <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>*; <a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hypovolaemia, hypovolaemic shock, haemorrhagic shock</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>*; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>*; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>; <a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ALI, ARDS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spontaneous subarachnoid haemorrhage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0005" title="BentsenG , BreivikH , LundarT , StubhaugA . Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo‐controlled study involving stable patients with subarachnoid hemorrhage. Critical Care Medicine2006;34(12):2912‐7. [17075367] ">Bentsen 2006</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dengue shock syndrome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postcardiac arrest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Perforation peritonitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe malaria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe febrile illness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe pulmonary insufficiency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vascular leak syndrome (cancer patients)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cirrhosis and septic induced hypotension</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe acute pancreatitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>* included for more than one type of condition</p> <p><b>ALI:</b> acute lung injury<br/> <b>ARDS:</b> acute respiratory distress syndrome<br/> <b>ICU:</b> intensive care unit </p> </div> </div> <p>Seven studies recruited only children (<a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>), and two studies recruited children and adults (<a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>). We noted that some studies reported an inclusion criteria of over 15 years of age (<a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>), over 16 years of age (<a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0037" title="MasoumiK , ForouzanA , DarianAA , Rafaty NavaiiA . Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. Journal of Clinical Medicine Research2016;8(11):815‐8. [PUBMED: 27738483] ">Masoumi 2016</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>), or over 17 years of age (<a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>); using mean ages reported by study authors, most participants in these studies were adults over 18 years of age. All remaining studies included only adult participants. </p> </section> <section id="CD000567-sec-0071"> <h5 class="title">Study setting</h5> <p>Nineteen studies were multicentre studies (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>); the remaining studies were single‐centre studies. </p> <p>Ten studies were based in an out‐of‐hospital setting before transition to an emergency or trauma department within a hospital (<a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0021" title="Grba‐BujevicM , Bosan‐KilibardaI , StrikicN . The use of hypertonic‐hyperoncotic solution for hypovolemic shock in trauma patients in prehospital setting. Neurologia Croatica2012;61(Suppl 2):21‐4. ">Grba‐Bujevic 2012</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>); the remaining studies were based in a hospital. </p> <p>Most single‐ or multicentre studies were conducted in one of the following countries: the USA (<a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>); Canada (<a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0017" title="ErnestD , BelzbergAS , DodekPM . Distribution of normal saline and 5% albumin infusions in septic patients. Critical Care Medicine1999;27(1):46‐50. [PUBMED: 9934892] ">Ernest 1999</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>); China (<a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>); Brazil (<a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>); India (<a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>; <a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>); Vietnam (<a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>); Norway (<a href="./references#CD000567-bbs2-0005" title="BentsenG , BreivikH , LundarT , StubhaugA . Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo‐controlled study involving stable patients with subarachnoid hemorrhage. Critical Care Medicine2006;34(12):2912‐7. [17075367] ">Bentsen 2006</a>; <a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a>); South Africa (<a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>); the UK (<a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>); Argentina (<a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>); Croatia (<a href="./references#CD000567-bbs2-0021" title="Grba‐BujevicM , Bosan‐KilibardaI , StrikicN . The use of hypertonic‐hyperoncotic solution for hypovolemic shock in trauma patients in prehospital setting. Neurologia Croatica2012;61(Suppl 2):21‐4. ">Grba‐Bujevic 2012</a>); Denmark (<a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>); Germany (<a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>); Iran (<a href="./references#CD000567-bbs2-0037" title="MasoumiK , ForouzanA , DarianAA , Rafaty NavaiiA . Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. Journal of Clinical Medicine Research2016;8(11):815‐8. [PUBMED: 27738483] ">Masoumi 2016</a>); Italy (<a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>); Kenya (<a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>); Mexico (<a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>); the Netherlands (<a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>); the Philippines (<a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>); Saudi Arabia (<a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>); Sweden (<a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>); Switzerland (<a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>); Taiwan (<a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>). </p> <p>Eight multicentre studies were conducted in more than one country (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>: France, Belgium, Canada, Algeria and Tunisia; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>: Denmark, Finland, Iceland and Norway; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>: Kenya, Tanzania and Uganda; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a> and <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>: USA and Canada; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a> and <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>: Australia and New Zealand; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>: France and Germany). </p> </section> <section id="CD000567-sec-0072"> <h5 class="title">Interventions and comparison</h5> <p>Nine studies were multi‐arm studies that included more than one colloid solution or more than one crystalloid solution or more than one of each type of solution (<a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>). One study compared colloids with crystalloids and the type of colloid or crystalloid was at the discretion of the physician (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>); types of colloids in this study were starches, gelatins, and albumin. </p> <section id="CD000567-sec-0073"> <h6 class="title">Colloids</h6> <p>Twenty‐eight studies used a starch solution (hydroxyethyl starch, hetastarch, or pentastarch) for fluid resuscitation (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0005" title="BentsenG , BreivikH , LundarT , StubhaugA . Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo‐controlled study involving stable patients with subarachnoid hemorrhage. Critical Care Medicine2006;34(12):2912‐7. [17075367] ">Bentsen 2006</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0021" title="Grba‐BujevicM , Bosan‐KilibardaI , StrikicN . The use of hypertonic‐hyperoncotic solution for hypovolemic shock in trauma patients in prehospital setting. Neurologia Croatica2012;61(Suppl 2):21‐4. ">Grba‐Bujevic 2012</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0037" title="MasoumiK , ForouzanA , DarianAA , Rafaty NavaiiA . Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. Journal of Clinical Medicine Research2016;8(11):815‐8. [PUBMED: 27738483] ">Masoumi 2016</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>). Of these, sixteen studies did not describe what they used as a suspension solution (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>). Five studies used a starch solution combined with an isotonic crystalloid solution, which was normal saline (<a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0037" title="MasoumiK , ForouzanA , DarianAA , Rafaty NavaiiA . Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. Journal of Clinical Medicine Research2016;8(11):815‐8. [PUBMED: 27738483] ">Masoumi 2016</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>), and seven studies used a starch solution combined with a hypertonic crystalloid solution, which was hypertonic saline (<a href="./references#CD000567-bbs2-0005" title="BentsenG , BreivikH , LundarT , StubhaugA . Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo‐controlled study involving stable patients with subarachnoid hemorrhage. Critical Care Medicine2006;34(12):2912‐7. [17075367] ">Bentsen 2006</a>; <a href="./references#CD000567-bbs2-0021" title="Grba‐BujevicM , Bosan‐KilibardaI , StrikicN . The use of hypertonic‐hyperoncotic solution for hypovolemic shock in trauma patients in prehospital setting. Neurologia Croatica2012;61(Suppl 2):21‐4. ">Grba‐Bujevic 2012</a>; <a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>), or Ringer's lactate (<a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>). Two studies did not specify the type of crystalloid solution that was combined with a starch (<a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>), and one multi‐arm study also included a starch combined with glutamine (<a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>). </p> <p>Twenty studies used dextrans for fluid resuscitation (<a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>). Two studies did not describe what they used as a suspension solution in dextran 70 (<a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>); <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a> gave Ringer's lactate to all participants after an initial infusion of dextran 70. Three studies used dextran 70 (which has relative molecular mass of 70,000) combined with an isotonic crystalloid solution which was normal saline (<a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). Eleven studies used hypertonic saline with 6% dextran 70 solution (HSD 6%) (<a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>). Three studies used hypertonic saline with dextran 70; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a> used it at 12%, while <a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a> used it at 4.2% and <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a> used it at 8%. One study used hypertonic saline with dextran 60 (a relative molecular mass of 60,000 (HSD 6%)) (<a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>). One study changed concentration of HSD during the study period; participants were initially given HSD 4.2% with dextran 70 before a protocol change to HSD 6% with dextran 70 (<a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>). </p> <p>Seven studies used a succinylated gelatin solution (of an isotonic composition) for fluid resuscitation (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a><a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>). </p> <p>Twenty‐two studies used albumin or FFP for fluid resuscitation. Thirteen studies used albumin (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0017" title="ErnestD , BelzbergAS , DodekPM . Distribution of normal saline and 5% albumin infusions in septic patients. Critical Care Medicine1999;27(1):46‐50. [PUBMED: 9934892] ">Ernest 1999</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>). Three studies used albumin combined with an isotonic crystalloid, which was normal saline (<a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>), and five studies used albumin combined with a hypertonic crystalloid, which was hypertonic saline (<a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>), or Ringer's lactate (<a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>). One study used FFP with Ringer's lactate (<a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>). </p> <p>Individual study protocols for the concentration, quantity, and timing of administration of each type of study colloid varied. We were not able to establish volume ratios of colloid solutions to crystalloid solutions in most studies; we found that study authors often reported that fluids were provided by the pharmacist and manufacturers in pre‐packaged bags, which we assumed contained fluids in clinically appropriate volume ratios. </p> </section> <section id="CD000567-sec-0074"> <h6 class="title">Crystalloids</h6> <p>Thirty‐four studies used isotonic solutions as the comparative crystalloid fluid, which was normal saline (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0005" title="BentsenG , BreivikH , LundarT , StubhaugA . Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo‐controlled study involving stable patients with subarachnoid hemorrhage. Critical Care Medicine2006;34(12):2912‐7. [17075367] ">Bentsen 2006</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0017" title="ErnestD , BelzbergAS , DodekPM . Distribution of normal saline and 5% albumin infusions in septic patients. Critical Care Medicine1999;27(1):46‐50. [PUBMED: 9934892] ">Ernest 1999</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0021" title="Grba‐BujevicM , Bosan‐KilibardaI , StrikicN . The use of hypertonic‐hyperoncotic solution for hypovolemic shock in trauma patients in prehospital setting. Neurologia Croatica2012;61(Suppl 2):21‐4. ">Grba‐Bujevic 2012</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0037" title="MasoumiK , ForouzanA , DarianAA , Rafaty NavaiiA . Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. Journal of Clinical Medicine Research2016;8(11):815‐8. [PUBMED: 27738483] ">Masoumi 2016</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>). </p> <p>Forty‐one studies used a hypertonic solution, which was Ringer's lactate (<a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>), Ringer's acetate (<a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>), or hypertonic saline (<a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>). </p> <p>One study used Ringer's acetate and normal saline (<a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a>), and three studies did not specify the type of crystalloid (<a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>). </p> <p>Individual study protocols for the quantity and timing of administration of each type of study crystalloid varied. </p> </section> </section> <section id="CD000567-sec-0075"> <h5 class="title">Outcomes</h5> <p>Only five studies did not report mortality data (<a href="./references#CD000567-bbs2-0005" title="BentsenG , BreivikH , LundarT , StubhaugA . Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo‐controlled study involving stable patients with subarachnoid hemorrhage. Critical Care Medicine2006;34(12):2912‐7. [17075367] ">Bentsen 2006</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0017" title="ErnestD , BelzbergAS , DodekPM . Distribution of normal saline and 5% albumin infusions in septic patients. Critical Care Medicine1999;27(1):46‐50. [PUBMED: 9934892] ">Ernest 1999</a>; <a href="./references#CD000567-bbs2-0021" title="Grba‐BujevicM , Bosan‐KilibardaI , StrikicN . The use of hypertonic‐hyperoncotic solution for hypovolemic shock in trauma patients in prehospital setting. Neurologia Croatica2012;61(Suppl 2):21‐4. ">Grba‐Bujevic 2012</a>; <a href="./references#CD000567-bbs2-0037" title="MasoumiK , ForouzanA , DarianAA , Rafaty NavaiiA . Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. Journal of Clinical Medicine Research2016;8(11):815‐8. [PUBMED: 27738483] ">Masoumi 2016</a>); these five studies did not report any of our review outcomes. Fourteen studies reported number of participants who required transfusion of blood products (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). Thirteen studies reported number of participants who required renal replacement therapy (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>). </p> <p>Nine studies reported data for adverse events (<a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>); seven reported incidences of allergic reaction (<a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>), two reported incidences of itching (<a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>), and two reported incidences of rashes (<a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). </p> </section> <section id="CD000567-sec-0076"> <h5 class="title">Funding sources</h5> <p>Thirty‐nine studies reported funding from departments or other sources that we judged to be independent (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>). Nineteen studies reported funding from pharmaceutical companies, which may have supplied study fluids (<a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>). We noted that one study with pharmaceutical funding reported that funders were involved in the study design, analysis and preparation of the report (<a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>). </p> <p>The remaining studies did not report funding sources or declare conflicts of interest.</p> </section> </section> <section id="CD000567-sec-0077"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD000567-sec-0176" title="">Characteristics of excluded studies</a>. </p> <p>We excluded 127 studies following consideration of the full‐text reports. Ninety‐three reports were of an ineligible study design (studies that were not RCTs, or were commentaries or editorial reports), nine studies had an ineligible participant group, and 25 studies used ineligible interventions (did not compare a colloid versus crystalloid, or fluids given at the wrong time). See <a href="#CD000567-fig-0001">Figure 1</a>. </p> <p>We have not included references and details of all 127 studies excluded during full‐text review, only the 31 that we considered to be key excluded studies (<a href="./references#CD000567-bbs2-0129" title="HigginsJP , DeeksJ , editor(s) . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <p>Because of changes to the criteria for considering studies since the last version of the review (<a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a>), we excluded 31 studies that were previously included and have listed these in the review. Reasons for excluding these studies were: in 28 studies fluid resuscitation was given as part of perioperative management of people undergoing elective surgery (<a href="./references#CD000567-bbs2-0070" title="BoutrosAR , RuessR , OlsonL , HoytJL , BakerWH . Comparison of hemodynamic, pulmonary, and renal effects of use of three types of fluids after major surgical procedures on the abdominal aorta. Critical Care Medicine1979;7(1):9‐13. [PUBMED: 367709] ">Boutros 1979</a>; <a href="./references#CD000567-bbs2-0072" title="DawidsonIJ , WillmsCD , SandorZF , CoorpenderLL , ReischJS , FryWJ . Ringer's lactate with or without 3% dextran‐60 as volume expanders during abdominal aortic surgery. Critical Care Medicine1991;19(1):36‐42. [PUBMED: 1702696] ">Dawidson 1991</a>; <a href="./references#CD000567-bbs2-0073" title="DehneMG , MühlingJ , SablotzkiA , DehneK , SuckeN , HempelmannG . Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment. Journal of Clinical Anesthesia2001;13(2):103‐11. [PUBMED: 11331169] ">Dehne 2001</a>; <a href="./references#CD000567-bbs2-0074" title="EleftheriadisS , Sedemund AdibB , KlotzKF , HubnerN , KuppeH . Volume replacement after cardiac surgery: comparison of Ringer, HES 6% and gelatine 3.5%. Intensive Care Medicine1995;21(Suppl 1):S216. ">Eleftheriadis 1995</a>; <a href="./references#CD000567-bbs2-0075" title="EvansPA , HeptinstallS , CrowhurstEC , DaviesT , GlennJR , MadiraW , et al. Prospective double‐blind randomized study of the effects of four intravenous fluids on platelet function and hemostasis in elective hip surgery. Journal of Thrombosis and Haemostasis2003;10(1):2140‐8. [PUBMED: 14521596] ">Evans 2003</a>; <a href="./references#CD000567-bbs2-0076" title="FriesD , StreifW , MargreiterJ , KlinglerA , KuhbacherG , SchobersbergerW , et al. The effects of perioperatively administered crystalloids and colloids on concentrations of molecular markers of activated coagulation and fibrinolysis. Blood Coagulation and Fibrinolysis2004;15(3):213‐9. [PUBMED: 15060416] ">Fries 2004</a>; <a href="./references#CD000567-bbs2-0077" title="GallagherJD , MooreRA , KernsD , JoseAB , BotrosSB , FlickerS , et al. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesthesia and Analgesia1985;64(8):753‐8. [PUBMED: 2409845] ">Gallagher 1985</a>; <a href="./references#CD000567-bbs2-0079" title="GuoXY , XuZH , RenHZ , LuoAL , HuangYG , YeTH . Effect of volume replacement with hydroxyethyl starch solution for blood loss on splanchnic oxygenation in patients undergoing cytoreductive surgery for ovarian carcinoma. Zhonghua Yi Xue Za Zhi2003;83(2):114‐7. [PUBMED: 12812678] ">Guo 2003</a>; <a href="./references#CD000567-bbs2-0080" title="HartmannM , JonssonK , ZederfeldtB . Effects of dextran and crystalloids on subcutaneous oxygen tension and collagen accumulation. A randomized study in surgical patients. European Surgical Research1993;25(5):270‐7. [PUBMED: 7691604] ">Hartmann 1993</a>; <a href="./references#CD000567-bbs2-0081" title="HondebrinkY , JeekelL , NijhuisJO , WoittiezAJ . Restoration of colloid osmotic pressure in hypoalbuminaemic patients. Intensive Care Medicine1997;23(Suppl 1):S184. TimmerB , HondebrinkJ , Oude NijhuisJ , WoittiezAJ . Restoration of colloid osmotic pressure in hypoalbuminaemic patients. Netherlands Journal of Medicine1998;52:A42. ">Hondebrink 1997</a>; <a href="./references#CD000567-bbs2-0082" title="KarankoMS , KlossnerJA , LaaksonenVO . Restoration of volume by crystalloid versus colloid after coronary artery bypass: hemodynamics, lung water, oxygenation, and outcome. Critical Care Medicine1987;15(6):559‐66. [PUBMED: 2436856] ">Karanko 1987</a>; <a href="./references#CD000567-bbs2-0083" title="LeeJS , AhnSW , SongJW , ShimJK , YooKJ , KwakYL . Effect of hydroxyethyl starch 130/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off‐pump coronary artery bypass graft surgery. Circulation Journal2011;75(10):2397‐402. [PUBMED: 21817820] ">Lee 2011</a>; <a href="./references#CD000567-bbs2-0084" title="LeySJ , MillerK , SkovP , PreisigP . Crystalloid versus colloid fluid therapy after cardiac surgery. Heart and Lung: Journal of Critical Care1990;19(1):31‐40. [PUBMED: 20045823] ">Ley 1990</a>; <a href="./references#CD000567-bbs2-0085" title="MazharR , SamenescoA , RoystonD , ReesA . Cardiopulmonary effects of 7.2% saline solution compared with gelatin infusion in the early postoperative period after coronary artery bypass grafting. Journal of Thoracic &amp; Cardiovascular Surgery1998;115(1):178‐89. [PUBMED: 9451062 ] ">Mazher 1998</a>; <a href="./references#CD000567-bbs2-0086" title="McNultySE , SharkeySJ , AsamB , LeeJH . Evaluation of STAT‐CRIT hematocrit determination in comparison to Coulter and centrifuge: the effects of isotonic hemodilution and albumin administration. Anesthesia and Analgesia1993;76(4):830‐4. [PUBMED: 23107606] ">McNulty 1993</a>; <a href="./references#CD000567-bbs2-0087" title="MorettiEW , RobertsonKM , El‐MoalemH , GanTJ . Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration. Anesthesia and Analgesia2003;96(2):611‐7. [PUBMED: 12538221] ">Moretti 2003</a>; <a href="./references#CD000567-bbs2-0088" title="NielsenOM , EngellHC . Extracellular fluid volume and distribution in relation to changes in plasma colloid osmotic pressure after major surgery. A randomized study. Acta Chirurgica Scandinavica1985;151(3):221‐5. [PUBMED: 3892993] ">Nielsen 1985</a>; <a href="./references#CD000567-bbs2-0089" title="PrienT , BackhausN , PelsterF , PircherW , BunteH , LawinP . Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. Journal of Clinical Anesthesia1990;2(5):317‐23. [PUBMED: 1702977 ] ">Prien 1990</a>; <a href="./references#CD000567-bbs2-0091" title="ShiresGT3rd , PeitzmanAB , AlbertSA , IllnerH , SilaneMF , PerryMO , et al. Response of extravascular lung water to intraoperative fluids. Annals of Surgery1983;197(5):515‐9. [PUBMED: 6847271] ">Shires 1983</a>; <a href="./references#CD000567-bbs2-0092" title="SirieixD , HongnatJM , DelayanceS , D'AttellisN , VicautE , BerrebiA , et al. Comparison of the acute hemodynamic effects of hypertonic or colloid infusions immediately after mitral valve repair. Critical Care Medicine1999;27(10):2159‐65. [PUBMED: 10548199 ] ">Sirieix 1999</a>; <a href="./references#CD000567-bbs2-0093" title="SkillmanJJ , RestallDS , SalzmanEW . Randomized trial of albumin vs. electrolyte solutions during abdominal aortic operations. Surgery1975;78(3):291‐303. [PUBMED: 1154272 ] ">Skillman 1975</a>; <a href="./references#CD000567-bbs2-0094" title="TollofsrudS , SvennevigJL , BreivikH , KongsgaardU , OzerM , HysingE , et al. Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiologica Scandinavica1995;39(5):671‐7. [PUBMED: 7572019] ">Tollusfrud 1995</a>; <a href="./references#CD000567-bbs2-0095" title="TollofsrudS , NoddelandH . Hypertonic saline and dextran after coronary artery surgery mobilises fluid excess and improves cardiorespiratory functions. Acta Anaesthesiologica Scandinavica1998;42(2):154‐61. [PUBMED: 9509195] ">Tollusfrud 1998</a>; <a href="./references#CD000567-bbs2-0096" title="VerheijJ , VanLingenA , BeishuizenA , ChristiaansHM , DeJongJR , GirbesAR , et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Medicine2006;32(7):1030‐8. [PUBMED: 16791665] ">Verheij 2006</a>; <a href="./references#CD000567-bbs2-0097" title="VirgilioRW , RiceCL , SmithDE , JamesDR , ZarinsCK , HobelmannCF , et al. Crystalloid vs. colloid resuscitation: is one better? A randomized clinical study. Surgery1979;85(2):129‐39. [PUBMED: 419454] ">Virgilio 1979</a>; <a href="./references#CD000567-bbs2-0098" title="WahbaA , SendtnerE , StrotzerM , WildK , BirnbaumDE . Fluid therapy with Ringer's solution versus Haemaccel following coronary artery bypass surgery. Acta Anaesthesiologica Scandinavica1996;40(10):1227‐33. [PUBMED: 8986187] ">Wahba 1996</a>; <a href="./references#CD000567-bbs2-0099" title="ZetterstromH , HedstrandU . Albumin treatment following major surgery. I. Effects on plasma oncotic pressure, renal function and peripheral oedema. Acta Anaesthesioligica Scandinavica1981;25(2):125‐32. [PUBMED: 7324819 ] ">Zetterstorm 1981a</a>; <a href="./references#CD000567-bbs2-0100" title="ZetterstromH . Albumin treatment following major surgery. II. Effects on postoperative lung function and circulatory adaptation. Acta Anaesthesiologica Scandinavica1981;25(2):133‐41. [PUBMED: 7324820 ] ">Zetterstorm 1981b</a>); two studies were not RCTs (<a href="./references#CD000567-bbs2-0071" title="Bowser‐WallaceBH , CaldwellFTJr . Fluid requirements of severely burned children up to 3 years old: hypertonic lactated saline vs. Ringer's lactate‐colloid. Burns1986;12(8):549‐55. [PUBMED: 3454687] ">Bowser‐Wallace 1986</a>; <a href="./references#CD000567-bbs2-0078" title="GrundmannR , HeistermannS . Postoperative albumin infusion therapy based on colloid osmotic pressure. A prospectively randomized trial. Archives of Surgery1985;120(8):911‐5. [PUBMED: 3893389] GrundmannR , MeyerH . The significance of colloid osmotic pressure measurement after crystalloid and colloid infusions. Intensive Care Medicine1982;8(4):179‐86. [PUBMED: 7119271] ">Grundmann 1982</a>); and one study was an abstract of a study protocol where the full study was never published (<a href="./references#CD000567-bbs2-0090" title="Rochae Silva M , Poli de FigueiredoLF . Hypertonic‐hyperoncotic saline solution for the treatment of post‐traumatic hypotension in the emergency room. The Brazilian multi‐center trial. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. ">Rocha e Silva 1994</a>). In addition, we excluded five studies because the publications have been retracted; we have not listed references for these retracted publications. </p> <p>See <a href="#CD000567-sec-0043">Criteria for considering studies for this review</a> and <a href="#CD000567-sec-0173">Differences between protocol and review</a>. </p> <section id="CD000567-sec-0078"> <h5 class="title">Studies awaiting classification</h5> <p>Seven studies are awaiting classification (<a href="./references#CD000567-bbs2-0103" title="Abd El HalimMA , Elsaid HafezMH , MoktarAM , EladawyA , ElazizyHM . Impact of gelatins on perfusion of microcirculatory blood flow in patient with septic shock. In: 29th Annual Congress of the European Society of Intensive Care Medicine (ESICM), 2016 Oct 1‐5; Milan (Italy). Intensive Care Medicine Experimental2016. ">Halim 2016</a>; <a href="./references#CD000567-bbs2-0101" title="BulanovAI , GorodetskiiVM , ShulutkoEM , Vasil'evSA , OrelEB , MalofeevVN , et al. Effect of different colloid volume‐replacing solutions on a changed hemostasis system. Anesteziologiia i Reanimatologiia2004;2:25‐30. [PUBMED: 15206272] ">Bulanov 2004</a>; <a href="./references#CD000567-bbs2-0102" title="CharpentierJ , MiraJ‐P . Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study. Intensive Care Medicine2011;37(Suppl 1):S115. ">Charpentier 2011</a>; <a href="./references#CD000567-bbs2-0104" title='NCT00890383 . Colloids in severe trauma [Colloids in severe trauma: a multi‐center pilot study of "crystalloid only" or "crystalloid + colloid" volume resuscitation in trauma patients (CIST)]. clinicaltrials.gov/ct2/show/record/NCT00890383 (first received 29 April 2009). '>NCT00890383</a>; <a href="./references#CD000567-bbs2-0105" title="NCT01337934 . Ringer versus albumin in septic patients: a randomized controlled clinical trial [Lactated Ringer versus albumin in early sepsis therapy (RASP)]. clinicaltrials.gov/ct2/show/NCT01337934 (first received 13 April 2011). ">NCT01337934</a>; <a href="./references#CD000567-bbs2-0106" title="NCT02064075 . The mortality and changes in quality of life of patients suffering from SAH with different hydration strategies [Phase 4 prospective, randomized, blinded study on the effect of different hydration strategies on mortality and changes in quality of life of patients suffering from subarachnoid haemorrhage]. clinicaltrials.gov/ct2/show/record/NCT02064075 (first received 17 February 2014). ">NCT02064075</a>; <a href="./references#CD000567-bbs2-0107" title="ProtsenkoDN , LeidermanIN , Grigor'evEV , KokarevEA , LevitAL , Gel'fandBR . Evaluation of the effectiveness and safety of synthetic colloid solutions in the treatment of severe abdominal sepsis: a randomized comparative study. Anesteziologiia i Reanimatologiia2009;5:9‐13. [PUBMED: 19938709] ">Protsenko 2009</a>). </p> <p>We found three studies during the searches of clinical trials registers (<a href="./references#CD000567-bbs2-0104" title='NCT00890383 . Colloids in severe trauma [Colloids in severe trauma: a multi‐center pilot study of "crystalloid only" or "crystalloid + colloid" volume resuscitation in trauma patients (CIST)]. clinicaltrials.gov/ct2/show/record/NCT00890383 (first received 29 April 2009). '>NCT00890383</a>; <a href="./references#CD000567-bbs2-0105" title="NCT01337934 . Ringer versus albumin in septic patients: a randomized controlled clinical trial [Lactated Ringer versus albumin in early sepsis therapy (RASP)]. clinicaltrials.gov/ct2/show/NCT01337934 (first received 13 April 2011). ">NCT01337934</a>; <a href="./references#CD000567-bbs2-0106" title="NCT02064075 . The mortality and changes in quality of life of patients suffering from SAH with different hydration strategies [Phase 4 prospective, randomized, blinded study on the effect of different hydration strategies on mortality and changes in quality of life of patients suffering from subarachnoid haemorrhage]. clinicaltrials.gov/ct2/show/record/NCT02064075 (first received 17 February 2014). ">NCT02064075</a>). These studies were described as completed but study results were not available; we await publication of the full reports to assess their eligibility for inclusion in the review. One study compared tetrastarch versus an unspecified crystalloid for fluid resuscitation following trauma (<a href="./references#CD000567-bbs2-0104" title='NCT00890383 . Colloids in severe trauma [Colloids in severe trauma: a multi‐center pilot study of "crystalloid only" or "crystalloid + colloid" volume resuscitation in trauma patients (CIST)]. clinicaltrials.gov/ct2/show/record/NCT00890383 (first received 29 April 2009). '>NCT00890383</a>); one study compared albumin versus Ringer's lactate for fluid resuscitation for sepsis and septic shock (<a href="./references#CD000567-bbs2-0105" title="NCT01337934 . Ringer versus albumin in septic patients: a randomized controlled clinical trial [Lactated Ringer versus albumin in early sepsis therapy (RASP)]. clinicaltrials.gov/ct2/show/NCT01337934 (first received 13 April 2011). ">NCT01337934</a>); and one study compared hydroxyethyl starch versus Ringer's lactate for fluid resuscitation following subarachnoid haemorrhage (<a href="./references#CD000567-bbs2-0106" title="NCT02064075 . The mortality and changes in quality of life of patients suffering from SAH with different hydration strategies [Phase 4 prospective, randomized, blinded study on the effect of different hydration strategies on mortality and changes in quality of life of patients suffering from subarachnoid haemorrhage]. clinicaltrials.gov/ct2/show/record/NCT02064075 (first received 17 February 2014). ">NCT02064075</a>). Two studies were published only as abstracts with insufficient information; one compared gelatin versus normal saline for fluid resuscitation for sepsis and septic shock (<a href="./references#CD000567-bbs2-0103" title="Abd El HalimMA , Elsaid HafezMH , MoktarAM , EladawyA , ElazizyHM . Impact of gelatins on perfusion of microcirculatory blood flow in patient with septic shock. In: 29th Annual Congress of the European Society of Intensive Care Medicine (ESICM), 2016 Oct 1‐5; Milan (Italy). Intensive Care Medicine Experimental2016. ">Halim 2016</a>), and one compared albumin versus normal saline for fluid resuscitation for septic shock (<a href="./references#CD000567-bbs2-0102" title="CharpentierJ , MiraJ‐P . Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study. Intensive Care Medicine2011;37(Suppl 1):S115. ">Charpentier 2011</a>). Two studies were published in Russian and require translation to assess eligibility: one compared starches with normal saline (<a href="./references#CD000567-bbs2-0101" title="BulanovAI , GorodetskiiVM , ShulutkoEM , Vasil'evSA , OrelEB , MalofeevVN , et al. Effect of different colloid volume‐replacing solutions on a changed hemostasis system. Anesteziologiia i Reanimatologiia2004;2:25‐30. [PUBMED: 15206272] ">Bulanov 2004</a>), and no details are known about the other study (<a href="./references#CD000567-bbs2-0107" title="ProtsenkoDN , LeidermanIN , Grigor'evEV , KokarevEA , LevitAL , Gel'fandBR . Evaluation of the effectiveness and safety of synthetic colloid solutions in the treatment of severe abdominal sepsis: a randomized comparative study. Anesteziologiia i Reanimatologiia2009;5:9‐13. [PUBMED: 19938709] ">Protsenko 2009</a>). See <a href="./references#CD000567-sec-0177" title="">Characteristics of studies awaiting classification</a>. </p> </section> <section id="CD000567-sec-0079"> <h5 class="title">Ongoing studies</h5> <p>We found three ongoing studies during searches of clinical trial registers (<a href="./references#CD000567-bbs2-0108" title="NCT01763853 . Impact of fluid resuscitation therapy on pulmonary edema as measured by alveolar fluid clearance in patients with acute respiratory distress syndrome (ARDS). clinicaltrials.gov/ct2/show/record/NCT01763853 (first received 9 January 2013). ">NCT01763853</a>; <a href="./references#CD000567-bbs2-0109" title="NCT02721238 . Comparison of colloid (20% albumin) versus crystalloid (Plasmalyte) for fluid resuscitation in cirrhotics with sepsis induced hypotension. clinicaltrials.gov/ct2/show/record/NCT02721238 (first received 29 March 2016). ">NCT02721238</a>; <a href="./references#CD000567-bbs2-0110" title="NCT02782819 . A comparison of crystalloid alone versus crystalloid plus colloid in shock resuscitation [A randomized controlled trial of crystalloid alone versus crystalloid plus colloid in shock resuscitation]. clinicaltrials.gov/ct2/show/record/NCT02782819 (first received 16 May 2016). ">NCT02782819</a>). One study compares 4% albumin versus an unspecified crystalloid in people with acute respiratory distress syndrome (<a href="./references#CD000567-bbs2-0108" title="NCT01763853 . Impact of fluid resuscitation therapy on pulmonary edema as measured by alveolar fluid clearance in patients with acute respiratory distress syndrome (ARDS). clinicaltrials.gov/ct2/show/record/NCT01763853 (first received 9 January 2013). ">NCT01763853</a>); one study compares 20% albumin versus plasmalyte in people with cirrhosis‐ and sepsis‐induced hypotension (<a href="./references#CD000567-bbs2-0109" title="NCT02721238 . Comparison of colloid (20% albumin) versus crystalloid (Plasmalyte) for fluid resuscitation in cirrhotics with sepsis induced hypotension. clinicaltrials.gov/ct2/show/record/NCT02721238 (first received 29 March 2016). ">NCT02721238</a>); and the last study compares 5% albumin or gelatin versus Ringer's lactate or normal saline for treatment of shock (<a href="./references#CD000567-bbs2-0110" title="NCT02782819 . A comparison of crystalloid alone versus crystalloid plus colloid in shock resuscitation [A randomized controlled trial of crystalloid alone versus crystalloid plus colloid in shock resuscitation]. clinicaltrials.gov/ct2/show/record/NCT02782819 (first received 16 May 2016). ">NCT02782819</a>). See <a href="./references#CD000567-sec-0178" title="">Characteristics of ongoing studies</a>. </p> </section> </section> </section> <section id="CD000567-sec-0080"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD000567-fig-0002">Figure 2</a> and <a href="#CD000567-fig-0003">Figure 3</a>. </p> <p>We did not complete 'Risk of bias' assessments for studies that reported none of our review outcomes (<a href="./references#CD000567-bbs2-0005" title="BentsenG , BreivikH , LundarT , StubhaugA . Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo‐controlled study involving stable patients with subarachnoid hemorrhage. Critical Care Medicine2006;34(12):2912‐7. [17075367] ">Bentsen 2006</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0017" title="ErnestD , BelzbergAS , DodekPM . Distribution of normal saline and 5% albumin infusions in septic patients. Critical Care Medicine1999;27(1):46‐50. [PUBMED: 9934892] ">Ernest 1999</a>; <a href="./references#CD000567-bbs2-0021" title="Grba‐BujevicM , Bosan‐KilibardaI , StrikicN . The use of hypertonic‐hyperoncotic solution for hypovolemic shock in trauma patients in prehospital setting. Neurologia Croatica2012;61(Suppl 2):21‐4. ">Grba‐Bujevic 2012</a>; <a href="./references#CD000567-bbs2-0037" title="MasoumiK , ForouzanA , DarianAA , Rafaty NavaiiA . Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. Journal of Clinical Medicine Research2016;8(11):815‐8. [PUBMED: 27738483] ">Masoumi 2016</a>). </p> <p>We did not seek translation of studies that were published in Chinese (<a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>). We made 'Risk of bias' assessments from details available in the English abstracts, and from the baseline characteristics tables. </p> <section id="CD000567-sec-0081"> <h4 class="title">Allocation</h4> <p>All studies were described as randomised. Thirty studies reported adequate methods of randomisation and we judged these to have a low risk of bias for random sequence generation (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). Twenty‐four studies reported adequate methods of allocation concealment and we judged these to have a low risk of bias (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). </p> <p>Four studies were quasi‐randomised studies, and we believed that methods for random sequence generation and random allocation concealment were at high risk of selection bias (<a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>). Two studies were described as randomised but because of differences noted in the baseline characteristics table (<a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>), and unexplained differences in participant numbers (<a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>), we judged them to be at high risk of bias for random sequence generation. One study described "use of lots" to allocate participants to groups and, without additional details, we were uncertain whether this method was adequate and so assessed risk of bias of random sequence generation as unclear (<a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>). </p> <p>The remaining studies reported insufficient details of random sequence generation (<a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>), and random allocation concealment (<a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a>; <a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>), and we judged these to have an unclear risk of selection bias. </p> </section> <section id="CD000567-sec-0082"> <h4 class="title">Blinding</h4> <p>For the mortality outcome, we believed that lack of blinding was unlikely to influence performance, or influence outcome assessment, therefore, we judged all studies that reported mortality data as having a low risk of performance bias and a low risk of detection bias for mortality. </p> <p>For the remaining outcomes (transfusion of blood products, renal replacement therapy, and adverse events), we assessed whether methods had been used to disguise fluid types from clinicians, and from outcome assessors. Nine studies reported sufficient methods of blinding and we judged these to have low risk of performance bias (<a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). Two studies described methods of fluid administration as open‐label, in which differences between study fluids would be apparent to personnel; we judged these to have a high risk of performance bias (<a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>). Study authors in <a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> reported that clinicians were not blinded because of the immediate need for resuscitation; we judged this study to have a high risk of performance bias. We judged the remaining studies as having an unclear risk of performance bias because methods of blinding were not described (<a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>). </p> <p>Six studies reported sufficient methods of blinding of outcome assessors and we judged these to have a low risk of detection bias (<a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). We judged the remaining studies to have an unclear risk of detection bias because study authors reported insufficient methods of blinding of outcome assessors (<a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>). </p> </section> <section id="CD000567-sec-0083"> <h4 class="title">Incomplete outcome data</h4> <p>Two studies, published only as abstracts, appeared to have some discrepancies in mortality data and we could not be certain whether this was because of loss of participant data; we judged these studies to have unclear risk of attrition bias (<a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>). </p> <p>One study had an apparent loss of analysed participants for mortality, but not for transfusion of blood products, and we could not explain this difference in loss; we judged this study to have a high risk of attrition bias (<a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>). One study excluded three participants because of protocol deviations; because the study was small this represented a high loss and we judged the study to have an unclear risk of attrition bias (<a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>). One study noted that approximately 10% of participants did not meet eligibility criteria after randomisation, however these were included in an intention‐to‐treat (ITT) analysis; we judged this study to have an unclear risk of attrition bias because this was a large number of participants in an ITT analysis (<a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>). </p> <p>The remaining studies had no losses, or few losses that were explained, and we judged them all to have low risk of attrition bias. </p> </section> <section id="CD000567-sec-0084"> <h4 class="title">Selective reporting</h4> <p>We found prospective clinical trials registration reports for nine studies (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>). Outcomes were reported according to these trial registration documents in six studies and we judged these to have a low risk of selective reporting bias (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>). In one study, we noted that outcomes were added to the trials register documents after the start of the study, and we could not be certain whether selective reporting bias was introduced because of this (<a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>). In two studies, we noted that outcomes in the study report were not listed as outcomes in the clinical trials registration documents, and we judged these studies to have a high risk of selective reporting bias (<a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>). </p> <p>Three studies were registered retrospectively with clinical trials registers (<a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>); it was not feasible to use information from these clinical trials documents to assess risk of selective reporting bias. </p> <p>We could not be certain whether <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a> was prospectively registered because the available abstract report included the clinical trials register identification number but not the study dates; we judged this to have an unclear risk of selective reporting bias. </p> <p>All other studies did not provide clinical trials registration information, or references for published study protocols, and we were unable to assess risk of selective reporting bias for these studies. </p> <section id="CD000567-sec-0085"> <h5 class="title">Baseline characteristics</h5> <p>We noted no differences in baseline characteristics that we believed could introduce bias in 46 studies, and we judged these studies to have a low risk of bias (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>; <a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>). </p> <p>We noted an imbalance in some baseline characteristics in eleven studies (<a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>; <a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>). We could not be certain whether these imbalances could influence results and we judged these studies to have an unclear risk of bias. We noted differences in several baseline characteristics in one study and judged this to have a high risk of bias (<a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>). </p> <p>We could not assess comparability of baseline characteristics in four studies because these were either not reported or not reported by group (<a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>). </p> </section> </section> <section id="CD000567-sec-0086"> <h4 class="title">Other potential sources of bias</h4> <p>We noted that in 14 studies some participants were given, or may have been given, additional colloids in the crystalloid arm either before or during the study (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>); we judged all these studies to have a high risk of other bias. </p> <p>We noted that one study was published by a single author, and time between completion of the study and publication of the report was longer than expected (<a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>). We could not be certain whether this study was a primary publication, or a secondary publication of an existing or unknown study, and we judged it to have a high risk of bias. We noted differences in the reported number of deaths in <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a> according to different study reports, and these differences were unexplained; we judged this study to have a high risk of other bias. </p> <p>We could not be certain of other risks of bias in the Chinese studies for which we did not seek translation (<a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>), nor in studies that were published only as abstracts (<a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>); and we assessed these studies to have an unclear risk of other bias. </p> <p>We noted no other sources of bias in the remaining studies, and judged these all to have a low risk of other bias. </p> </section> </section> <section id="CD000567-sec-0087"> <h3 class="title" id="CD000567-sec-0087">Effects of interventions</h3> <p>See: <a href="./full#CD000567-tbl-0001"><b>Summary of findings for the main comparison</b> Starches compared to crystalloid for fluid resuscitation in critically ill patients</a>; <a href="./full#CD000567-tbl-0002"><b>Summary of findings 2</b> Dextrans compared to crystalloid for fluid resuscitation in critically ill patients</a>; <a href="./full#CD000567-tbl-0003"><b>Summary of findings 3</b> Gelatins compared to crystalloid for fluid resuscitation in critically ill patients</a>; <a href="./full#CD000567-tbl-0004"><b>Summary of findings 4</b> Albumin and fresh frozen plasma compared to crystalloid for fluid resuscitation in critically ill patients</a> </p> <section id="CD000567-sec-0088"> <h4 class="title">1. Starches versus crystalloids</h4> <section id="CD000567-sec-0089"> <h5 class="title">All‐cause mortality at end of follow‐up</h5> <p>Twenty‐five studies measured mortality (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>). </p> <p>We included 24 in this analysis, in which the time of the assessment point was: within 24 hours (<a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>); within the ICU or hospital stay (<a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>); up to 30 days from hospital discharge (<a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>); within 28 or 30 days (<a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>); within 60 days (<a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>); within 90 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>); at 12 months (<a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a>); and studies in which the time point was unknown (<a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>). We did not include mortality data reported in <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>, the data were reported as percentages in the abstract and we could not be certain whether the data were for all randomised participants or whether some participant data were lost. </p> <p>Three studies were multi‐arm studies. We combined data for both colloid groups in two studies (<a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>); and for both colloid groups and both crystalloid groups in <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>. One study, which allowed type of colloid or crystalloid to be at the discretion of the clinician, reported mortality outcome data for participants who received only one type of fluid (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>); we included data for participants who received only hydroxyethyl starch in the colloid group, and combined data for two crystalloid groups (isotonic saline, and Ringer's lactate). </p> <p>We found little or no difference in the number of participants who died at the end of follow‐up according to whether fluid resuscitation was with a starch or with a crystalloid (RR 0.97 95% CI 0.86 to 1.09; 11,177 participants; 24 studies; I² = 34%; <a href="./references#CD000567-fig-0007" title="">Analysis 1.1</a>). </p> <p>We generated a funnel plot to assess risk of publication bias and did not interpret this to indicate high risk (<a href="#CD000567-fig-0004">Figure 4</a>). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as moderate. We downgraded the evidence by one level for study limitations because some studies had an unclear risk of selection bias, one small study had a high risk of selection bias, and because, for many studies, we were unable to assess risk of selective reporting bias due to lack of prospective clinical trials registration. See <a href="./full#CD000567-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD000567-sec-0090"> <h5 class="title">All‐cause mortality within 90 days</h5> <p>Sixteen studies measured mortality within 90 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>). </p> <p>We included mortality data in this analysis in which the time point was: within 24 hours (<a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>); within the ICU or hospital stay (<a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>); up to 30 days from hospital discharge (<a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a>); within 28 or 30 days (<a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>); within 60 days (<a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>); or within 90 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>). We did not include the mortality data reported in <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>, as the data were not clearly reported in the abstract. </p> <p>Two studies were multi‐arm studies. We combined data for both colloid groups in <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a>, and for both colloid groups and both crystalloid groups in <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>. One study, which allowed type of colloid or crystalloid to be at the discretion of the clinician, reported mortality outcome data for participants who received only one type of fluid (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>). We included data for participants who received only hydroxyethyl starch in the colloid group, and combined data for two crystalloid groups (isotonic saline, and Ringer's lactate). </p> <p>We found little or no difference in the number of participants who died within 90 days according to whether fluid resuscitation was with a starch or with a crystalloid (RR 1.01, 95% CI 0.90 to 1.14; 10,415 participants; 15 studies; I² = 36%; <a href="./references#CD000567-fig-0008" title="">Analysis 1.2</a>). </p> <p>We generated a funnel plot to assess risk of publication bias and did not interpret this as indicating high risk. </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as moderate. We downgraded the evidence by one level for study limitations because some studies had an unclear risk of selection bias and because, for many studies, we were unable to assess risk of selective reporting bias due to lack of prospective clinical trials registration. See <a href="./full#CD000567-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD000567-sec-0091"> <h5 class="title">All‐cause mortality within 30 days</h5> <p>Twelve studies measured mortality within 30 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>). We did not include mortality data reported in <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>, as the data were not clearly reported in the abstract. </p> <p>One study was a multi‐arm study (<a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>); we combined data for both colloid groups and both crystalloid groups in this study. </p> <p>We included mortality data in this analysis in which the time point was: within 24 hours (<a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>); and within 28 or 30 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>). </p> <p>We found little or no difference in the number of participants who died within 30 days according to whether fluid resuscitation was with a starch or with a crystalloid (RR 0.99, 95% CI 0.90 to 1.09; 10,135 participants; 11 studies; I² = 12%; <a href="./references#CD000567-fig-0009" title="">Analysis 1.3</a>). </p> <p>We generated a funnel plot to assess risk of publication bias and did not interpret this as indicating high risk. </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as moderate. We downgraded the evidence by one level for study limitations because some studies had unclear risk of selection bias and because, for many studies, we were unable to assess risk of selective reporting bias due to lack of prospective clinical trials registration. See <a href="./full#CD000567-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD000567-sec-0092"> <h5 class="title">Transfusion of blood products</h5> <p>Nine studies reported the number of participants who required transfusion of blood products (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). </p> <p>One study, which allowed type of colloid or crystalloid to be at the discretion of the clinician, combined data for all types of colloids (hydroxyethyl starch, gelatins, or albumin), and we could not include these data in the analysis of starches (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>). We reported data for transfusion of blood products for this study in <a href="#CD000567-tbl-0006">Table 2</a>; we noted little or no difference between groups in the need for blood products according to type of fluid. </p> <div class="table" id="CD000567-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Data for outcomes with a single study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Events in colloid group: n/N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Events in crystalloid group:</b> </p> <p><b>n/N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Colloids (at the discretion of the clinician: HES, gelatins, or albumin) versus crystalloids</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Transfusion of blood products</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>377/1414</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>358/1443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.07, 95% CI 0.95 to 1.22; 2857 participants</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Renal replacement therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>156/1414</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>181/1443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.88, 95% CI 0.72 to 1.08; 2857 participants</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Gelatin versus crystalloids</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mortality (within 90 days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84/281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>346/1035</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.89, 95% CI 0.73 to 1.09; 1388 participants</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mortality (within 30 days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69/281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>275/1035</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.92, 95% CI 0.74 to 1.16; 1388 participants</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Albumin versus crystalloid</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events: allergic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/1050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/1047</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.75, 95% CI 0.17 to 3.33; 2097 participants</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>CI</b> : confidence interval<br/> <b>HES</b> : hydroxyethyl starch<br/> <b>n</b> : number of participants with an event<br/> <b>N</b> : number of participants randomised to group<br/> <b>RR</b>: risk ratio </p> </div> </div> <p>For the remaining eight studies, we found that more participants required a transfusion of blood product when starches were given (RR 1.19, 95% CI 1.02 to 1.39; 1917 participants; 8 studies; I² = 14%; <a href="./references#CD000567-fig-0010" title="">Analysis 1.4</a>). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as moderate. We downgraded the evidence by one level for study limitations because some studies had unclear risk of selection bias, one small study had a high risk of selection bias, and because, for many studies, we were unable to assess risk of selective reporting bias due to lack of prospective clinical trials registration. See <a href="./full#CD000567-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD000567-sec-0093"> <h5 class="title">Renal replacement therapy</h5> <p>Ten studies reported the number of participants who required renal replacement therapy or dialysis (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a>). </p> <p>One study, which allowed type of colloid or crystalloid to be at the discretion of the clinician, combined data for all types of colloids (hydroxyethyl starch, gelatins, or albumin), and we could not include these data in analysis of starches (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>). We reported data for renal replacement therapy for this study in <a href="#CD000567-tbl-0006">Table 2</a>; we noted little or no difference between groups in the need for renal replacement therapy according to type of fluid. </p> <p>We found that fewer participants were given renal replacement therapy when fluid resuscitation was with a crystalloid (RR 1.30, 95% CI 1.14 to 1.48; 8527 participants; 9 studies; I² = 0%; <a href="./references#CD000567-fig-0011" title="">Analysis 1.5</a>). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as moderate. We downgraded the evidence by one level for study limitations because some studies had unclear risk of selection bias and because, for many studies, we were unable to assess risk of selective reporting bias due to lack of prospective clinical trials registration. See <a href="./full#CD000567-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD000567-sec-0094"> <h5 class="title">Adverse events (allergic reaction, itching, rashes)</h5> <p>Six studies reported adverse event data for allergic reaction, itching, or rashes (<a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). </p> <section id="CD000567-sec-0095"> <h6 class="title">Allergic reaction</h6> <p>We found little or no difference in allergic reaction according to whether starches or crystalloids were used (RR 2.59, 95% CI 0.27 to 24.91; 7757 participants; 3 studies; I² = 0%; <a href="./references#CD000567-fig-0012" title="">Analysis 1.6</a>). </p> </section> <section id="CD000567-sec-0096"> <h6 class="title">Itching</h6> <p>We found fewer incidences of itching when participants were given crystalloids (RR 1.38, 95% CI 1.05 to 1.82; 6946 participants; 2 studies; I² = 0%; <a href="./references#CD000567-fig-0013" title="">Analysis 1.7</a>). </p> </section> <section id="CD000567-sec-0097"> <h6 class="title">Rashes</h6> <p>We found little or no difference in incidences of rashes (RR 1.61, 95% CI 0.90 to 2.89; 7007 participants; 2 studies; I² = 0%; <a href="./references#CD000567-fig-0014" title="">Analysis 1.8</a>). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for adverse events as very low. We downgraded the evidence by one level for study limitations because some studies had unclear risk of selection bias, and because, for many studies, we were unable to assess risk of selective reporting bias due to lack of prospective clinical trials registration. We downgraded the evidence by two levels for imprecision because few of our included studies reported data for these outcomes. See <a href="./full#CD000567-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> </section> </section> <section id="CD000567-sec-0098"> <h4 class="title">Subgroup analysis</h4> <section id="CD000567-sec-0099"> <h5 class="title">Tonicity of crystalloid solution</h5> <p>We found that many studies did not report the solution in which the colloid was suspended. Two studies compared a starch and isotonic crystalloid versus an isotonic crystalloid and reported mortality outcome data (<a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>), two studies compared a starch and isotonic crystalloid versus a hypertonic crystalloid (<a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>), and three studies compared a starch and hypertonic crystalloid versus a hypertonic crystalloid (<a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a>). We did not perform subgroup analysis on all‐cause mortality (at end of follow‐up) for this comparison because we had insufficient studies to do so meaningfully. </p> </section> </section> <section id="CD000567-sec-0100"> <h4 class="title">Sensitivity analysis</h4> <section id="CD000567-sec-0101"> <h5 class="title">Studies at high or unclear risk of selection bias</h5> <p>We excluded 10 studies that we judged to have unclear risk of selection bias (<a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>), and one study that we judged to have high risk of selection bias from analysis of the primary outcome (<a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>). This did not alter interpretation of the effect, with little or no difference between groups in all‐cause mortality (at end of follow‐up) when these studies were excluded (RR 1.03, 95% CI 0.91 to 1.17; 10,139 participants; 13 studies; I² = 34%). </p> </section> <section id="CD000567-sec-0102"> <h5 class="title">Studies in which some participants in the crystalloid group were given, or may have been given, additional colloids </h5> <p>Some studies were at risk of bias because some participants in the crystalloid group were given, or may have been given, additional colloids. We excluded seven studies from analysis of the primary outcome (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a>; <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). Although excluding these studies did not alter interpretation of the effect for analysis of all‐cause mortality (at end of follow‐up), we noted that without these studies statistical heterogeneity was reduced from 34% to 0% (RR 0.84, 95% CI 0.70 to 1.01; 1115 participants; 17 studies; I² = 0%). </p> </section> <section id="CD000567-sec-0103"> <h5 class="title">Alternative meta‐analytical effects model (fixed‐effect)</h5> <p>Using the alternative meta‐analytical effects model (fixed‐effect), we found no difference in interpretation of the effect, with little or no difference between groups in all‐cause mortality (at end of follow‐up) (RR 1.01, 95% CI 0.95 to 1.08; 11,177 participants; 24 studies; I² = 34%). </p> </section> <section id="CD000567-sec-0104"> <h5 class="title">Studies with discrepancies in data</h5> <p>In one study we noted discrepancies in mortality data within the study report (<a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>). We removed this study from analysis and found that it made no difference to interpretation of the effect, with little or no difference between groups in all‐cause mortality (at end of follow‐up) (RR 0.98, 95% CI 0.87 to 1.10; 11,152 participants; 23 studies; I² = 33%). </p> </section> </section> <section id="CD000567-sec-0105"> <h4 class="title">2. Dextrans versus crystalloids</h4> <section id="CD000567-sec-0106"> <h5 class="title">All‐cause mortality at end of follow‐up</h5> <p>Nineteen studies measured outcome data for mortality (<a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>). </p> <p>Six studies were multi‐arm studies. We combined data in analysis for both crystalloid groups in <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>, <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>, <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>, <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>, and <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>, and we combined data in analysis for both colloid groups and both crystalloid groups in <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>. </p> <p>We included mortality data in this analysis in which the time point was: within 24 hours (<a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>); within 48 hours (<a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>); until hospital discharge (<a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>); or was unknown (<a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). The remaining studies reported data at 28 or 30 days (<a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>). </p> <p>We found little or no difference in the number of participants who died at end of follow‐up according to whether fluid resuscitation was with dextran or with a crystalloid (RR 0.99, 95% CI 0.88 to 1.11; 4736 participants; 19 studies; I² = 7%; <a href="./references#CD000567-fig-0015" title="">Analysis 2.1</a>). </p> <p>We generated a funnel plot to assess risk of publication bias. One study was an outlier in this plot, which we could not explain, but, because the only outlier was a small study from 1991 (<a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>), we did not believe this was evidence of a high risk of publication bias. See <a href="#CD000567-fig-0005">Figure 5</a>. </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as moderate. We downgraded the evidence by one level for study limitations because some studies had unclear risk of selection bias and because, for many studies, we were unable to assess risk of selective reporting bias due to lack of prospective clinical trials registration. See <a href="./full#CD000567-tbl-0002">summary of findings Table 2</a>. </p> </section> <section id="CD000567-sec-0107"> <h5 class="title">All‐cause mortality within 90 days and within 30 days</h5> <p>Ten studies measured mortality within 30 days (<a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>). No studies reported mortality within 90 days, and we included the same data for both outcome time points for this comparison. </p> <p>Two studies were multi‐arm studies (<a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>). We combined the data in analysis for both crystalloid groups. </p> <p>We included mortality data in this analysis in which the time point was: within 24 hours (<a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>); within 48 hours (<a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>); and within 28 or 30 days (<a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>). </p> <p>We found little or no difference in the number of participants who died within 90 days and within 30 days according to whether fluid resuscitation was with dextran or with a crystalloid (RR 0.99, 95% CI 0.87 to 1.12; 3353 participants; 10 studies; I² = 0%; <a href="./references#CD000567-fig-0016" title="">Analysis 2.2</a>). </p> <p>We generated a funnel plot to assess risk of publication bias. One study was an outlier in this plot, which we could not explain, but, because the only outlier was a small study from 1991 (<a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>), we did not believe this was evidence of a high risk of publication bias. </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as moderate. We downgraded the evidence by one level for study limitations because some studies had unclear risk of selection bias and because, for many studies, we were unable to assess risk of selective reporting bias due to lack of prospective clinical trials registration. See <a href="./full#CD000567-tbl-0002">summary of findings Table 2</a>. </p> </section> <section id="CD000567-sec-0108"> <h5 class="title">Transfusion of blood products</h5> <p>Three studies reported the number of participants requiring a blood transfusion (<a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>, a multi‐arm study, reported blood transfusion of 9 units or fewer of blood, and 10 units or fewer of blood. In analysis, we combined data in the two crystalloids groups in <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a> for 9 units or fewer of blood. </p> <p>We found little or no difference in participants requiring a transfusion of blood products according to whether participants were given dextran or a crystalloid (RR 0.92, 95% CI 0.77 to 1.10; 1272 participants; 3 studies; I² = 0%; <a href="./references#CD000567-fig-0017" title="">Analysis 2.3</a>). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as very low. We downgraded the evidence by two levels for study limitations because we noted that in two studies some participants were given additional colloids in the crystalloid group, and in another study we could not be certain whether some participants in the crystalloids groups had also received up to 2000 mL colloid resuscitation prior to randomisation. In addition, we were unable to assess risk of selective reporting bias because, for many studies there was a lack of prospective clinical trials registration. See <a href="./full#CD000567-tbl-0002">summary of findings Table 2</a>. </p> </section> <section id="CD000567-sec-0109"> <h5 class="title">Renal replacement therapy</h5> <p>No studies reported data for this outcome.</p> </section> <section id="CD000567-sec-0110"> <h5 class="title">Adverse events (allergic reaction, itching, rashes)</h5> <p>Four studies reported allergic reactions (<a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>), with event data in only one study (<a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>). </p> <p>We found little or no difference between study fluids in cases of allergic reaction (RR 6.00, 95% CI 0.25 to 144.93; 739 participants; 4 studies; <a href="./references#CD000567-fig-0018" title="">Analysis 2.4</a>). </p> <p>We used the GRADE approach to downgrade the certainty of the evidence for adverse events to very low. We downgraded by one level for study limitations because one study had an unclear risk of selection bias and we were unable to assess risk of selective outcome reporting bias in all studies. We downgraded by two levels for imprecision because evidence was from few studies with few events. </p> </section> </section> <section id="CD000567-sec-0111"> <h4 class="title">Subgroup analysis</h4> <section id="CD000567-sec-0112"> <h5 class="title">Tonicity of crystalloid solution</h5> <p>Eight studies used a dextran solution with hypertonic saline (HSD) versus an isotonic crystalloid (which was normal saline) and reported mortality outcome data (<a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>); two studies used a dextran solution with an isotonic crystalloid versus a hypertonic crystalloid (Ringer's lactate) and reported mortality outcome data (<a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>); and five studies used HSD versus Ringer's lactate and reported mortality outcome data (<a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>). One multi‐arm study used two concentrations of HSD that were appropriate to combine in subgroup analysis versus two types of hypertonic crystalloid (hypertonic saline and Ringer's lactate), which were also appropriate to combine in subgroup analysis (<a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>). We did not include three studies in subgroup analysis because the type of crystalloid in which the dextran was suspended was not reported (<a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>), or a variety of crystalloids was used in the comparison group (<a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>). We found no evidence of a difference between studies in use of isotonic or hypertonic crystalloid solutions for all‐cause mortality (at end of follow‐up) (P = 0.92). See <a href="./references#CD000567-fig-0025" title="">Analysis 5.1</a>. </p> </section> </section> <section id="CD000567-sec-0113"> <h4 class="title">Sensitivity analysis</h4> <section id="CD000567-sec-0114"> <h5 class="title">Studies at high or unclear risk of selection bias</h5> <p>We judged two studies to have high risk of selection bias (<a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>), and five studies to have unclear risk of selection bias (<a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>), and excluded them from analysis of mortality. This did not alter interpretation of the effect for all‐cause mortality (at the end of follow‐up); there was little or no difference between groups when these studies were excluded (RR 1.03, 95% CI 0.91 to 1.16; 3940 participants; 12 studies; I² = 6%). </p> </section> <section id="CD000567-sec-0115"> <h5 class="title">Studies in which some participants in the crystalloid group were given, or may have been given, additional colloids </h5> <p>Some studies were at risk of bias because some participants in the crystalloid group were given, or may have been given additional colloids. We excluded six studies from analysis of mortality at end of follow‐up (<a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a>). This did not alter interpretation of the effect on all‐cause mortality (at end of follow‐up); there was little or no difference between groups when these studies were excluded (RR 1.00, 95% CI 0.88 to 1.15; 3185 participants; 13 studies; I² = 11%). </p> </section> <section id="CD000567-sec-0116"> <h5 class="title">Alternative meta‐analytical effects model (fixed‐effect)</h5> <p>Using the alternative meta‐analytical effects model (fixed‐effect), did not alter interpretation of the effect on all‐cause mortality (at end of follow‐up); there was little or no difference between groups when we used the fixed‐effect model (RR 0.99, 95% CI 0.89 to 1.10; 4570 participants; 18 studies; I² = 7%). </p> </section> <section id="CD000567-sec-0117"> <h5 class="title">Studies with discrepancies in data</h5> <p>We included no studies with serious discrepancies in data.</p> </section> </section> <section id="CD000567-sec-0118"> <h4 class="title">3. Gelatins versus crystalloids</h4> <section id="CD000567-sec-0119"> <h5 class="title">All‐cause mortality at end of follow‐up</h5> <p>Six studies reported outcome data for mortality (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>). One study reported the time point as within the ICU or hospital stay (<a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>), one study was at 90 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>), and the remaining time points were unknown. </p> <p>One study was a multi‐arm study (<a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>); we combined data in analysis for both crystalloid groups. </p> <p>One study, which allowed type of colloid or crystalloid to be at the discretion of the clinician, reported mortality outcome data for participants who received only one type of fluid (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>). We included data for participants who received only gelatins in the colloid group, and combined data for two crystalloid groups (isotonic saline and Ringer's lactate). </p> <p>We found little or no difference in the number of participants who had died from any cause at the end of follow‐up according to whether fluid resuscitation was with gelatins or with a crystalloid (RR 0.89, 95% CI 0.74 to 1.08; 1698 participants; 6 studies; I² = 0%; <a href="./references#CD000567-fig-0019" title="">Analysis 3.1</a>). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as low. We downgraded the evidence by one level for study limitations because risk of selection bias was unclear in some studies and we were unable to assess risk of selective outcome reporting bias in some studies that were not registered with clinical trials registers. We downgraded by one level for imprecision because evidence was from few studies, and we could not be certain of time points for data collection. <a href="./full#CD000567-tbl-0003">summary of findings Table 3</a>. </p> </section> <section id="CD000567-sec-0120"> <h5 class="title">All‐cause mortality within 90 days</h5> <p>One study reported mortality data at 90 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>). This study allowed the type of colloid or crystalloid to be at the discretion of the clinician and reported mortality outcome data for participants who received only one type of fluid. We combined data for the two crystalloid groups (normal saline and Ringer's lactate) and used RevMan 5 to calculate an effect estimate (<a href="./references#CD000567-bbs2-0140" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). Study data are reported in <a href="#CD000567-tbl-0006">Table 2</a>. </p> <p>We found little or no difference in the number of participants who died from any cause within 90 days according to whether fluid resuscitation was with gelatins or with a crystalloid (RR 0.89, 95% CI 0.73 to 1.09; 1388 participants; 1 study). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as low. We downgraded by two levels for imprecision because evidence was from a single study. </p> </section> <section id="CD000567-sec-0121"> <h5 class="title">All‐cause mortality within 30 days</h5> <p>One study reported mortality data at 28 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>). This study allowed type of colloid or crystalloid to be at the discretion of the clinician and reported mortality outcome data for participants who received only one type of fluid. We combined data for the two crystalloid groups (isotonic saline and Ringer's lactate) and used the RevMan 5 to calculate an effect estimate (<a href="./references#CD000567-bbs2-0140" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). Study data are reported in <a href="#CD000567-tbl-0006">Table 2</a>. </p> <p>We found little or no difference in the number of participants who died from any cause within 30 days according to whether fluid resuscitation was with gelatins or with a crystalloid (RR 0.92, 95% CI 0.74 to 1.16; 1388 participants; 1 study). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as low. We downgraded by two levels for imprecision because evidence was from a single study. </p> </section> <section id="CD000567-sec-0122"> <h5 class="title">Transfusion of blood products</h5> <p>Three studies measured the number of participants who needed a transfusion of blood products (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>). However, we could not use the data in <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>, because it was not reported by group (five participants overall required blood transfusion), and we could not report the data in <a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>, because it was not reported separately for participants who received only gelatins (we noted little or no difference between people receiving either hydroxyethyl starch, gelatins, or albumin; <a href="#CD000567-tbl-0006">Table 2</a>). </p> <p>The remaining study reported one participant in the gelatins group who required a blood transfusion following a severe epistaxis (<a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>). We used the calculator in RevMan 5 (<a href="./references#CD000567-bbs2-0140" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>), and found little or no difference between groups in need for blood transfusion (RR 5.89, 95% CI 0.24 to 142.41; 167 participants; 1 study). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as very low. We downgraded by one level for study limitations because we were unable to assess risk of selective outcome reporting bias due to lack of prospective clinical trials registration, and some participants in the crystalloid groups also received colloids. We downgraded two levels for imprecision because evidence was from a single small study with very few events. </p> </section> <section id="CD000567-sec-0123"> <h5 class="title">Renal replacement therapy</h5> <p>One study, which allowed type of colloid or crystalloid to be at the discretion of the clinician, reported number of participants who required renal replacement therapy but did not report these data according to type of colloid received (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>). We did not include these data in our analysis of gelatins because the types of colloid used were either hydroxyethyl starch, gelatins, or albumin. We included data for renal replacement therapy for <a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> in <a href="#CD000567-tbl-0006">Table 2</a>; we noted little or no difference between groups in the need for renal replacement therapy according to whether a colloid (hydroxyethyl starch, gelatins, or albumin) or a crystalloid was used. </p> </section> <section id="CD000567-sec-0124"> <h5 class="title">Adverse events (allergic reaction, itching, rashes)</h5> <p>One study reported that five participants in the gelatins group had an allergic reaction (<a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>). We used the calculator in RevMan 5 (<a href="./references#CD000567-bbs2-0140" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>), and found little or no difference between groups in incidences of allergic reactions (RR 21.61, 95% CI 1.22 to 384.05; 167 participants; 1 study). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as very low. We downgraded by one level for study limitations because we were unable to assess risk of selective outcome reporting bias due to lack of prospective clinical trials registration, and because some participants in the crystalloid groups also received colloids. We downgraded two levels for imprecision because evidence was from a single small study with very few events. </p> </section> </section> <section id="CD000567-sec-0125"> <h4 class="title">Subgroup analysis</h4> <section id="CD000567-sec-0126"> <h5 class="title">Tonicity of crystalloid solution</h5> <p>We found insufficient studies to conduct meaningful subgroup analysis. Of the six studies that reported mortality outcome data, five studies reported using a modified gelatin solution suspended in isotonic crystalloid solution. Two studies used Haemaccel (<a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>), two studies used Gelofusine (<a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a>), and one study used Gelafundin (<a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>). The remaining study, in which type of colloid solution was at the discretion of the clinician, did not specify the gelatin solution (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>). </p> </section> </section> <section id="CD000567-sec-0127"> <h4 class="title">Sensitivity analysis</h4> <section id="CD000567-sec-0128"> <h5 class="title">Studies at high or unclear risk of selection bias</h5> <p>We excluded one study that we judged to have an unclear risk of selection bias from analysis of mortality (<a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>). This did not alter interpretation of the effect for all‐cause mortality (at the end of follow‐up), with little or no difference between groups (RR 0.90, 95% CI 0.74 to 1.08; 1673 participants; 5 studies; I² = 0%). </p> </section> <section id="CD000567-sec-0129"> <h5 class="title">Studies in which some participants in the crystalloid group were given, or may have been given, additional colloids </h5> <p>Some studies were at risk of bias because some participants in the crystalloid group were given, or may have been given additional colloids. We excluded two studies from analysis of the primary outcome (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0046" title="NgoNT , CaoXT , KneenR , WillsB , NguyenVM , NguyenTQ , et al. Acute management of dengue shock syndrome: a randomized double‐blind comparison of 4 intravenous fluid regimens in the first hour. Clinical Infectious Diseases2001;32(2):204‐13. [PUBMED: 11170909] ">Ngo 2001</a>). This did not alter interpretation of the effect for all‐cause mortality (at the end of follow‐up), with little or no difference between groups (RR 0.94, 95% CI 0.52 to 1.72; 143 participants; 4 studies; I² = 0%). </p> </section> <section id="CD000567-sec-0130"> <h5 class="title">Alternative meta‐analytical effects model (fixed‐effect)</h5> <p>Using the alternative meta‐analytical effects model (fixed‐effect) did not alter interpretation of the effect for all‐cause mortality (at the end of follow‐up), with little or no difference between groups (RR 0.89, 95% CI 0.74 to 1.08; 1689 participants; 6 studies; I² = 0%). </p> </section> <section id="CD000567-sec-0131"> <h5 class="title">Studies with discrepancies in data</h5> <p>We included no studies with serious discrepancies in data.</p> </section> </section> <section id="CD000567-sec-0132"> <h4 class="title">4. Albumin or FFP versus crystalloids</h4> <section id="CD000567-sec-0133"> <h5 class="title">All‐cause mortality at end of follow‐up</h5> <p>Twenty‐one studies reported mortality (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>). One study was a multi‐arm study and we combined data in analysis for both crystalloid groups (<a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>). </p> <p>We did not include outcome data from one study (<a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>), as mortality data were reported overall, not by group (12 of 50 participants died). </p> <p>We included mortality data in this analysis in which the time point was: within 24 hours (<a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>); within seven days (<a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>); within the ICU or hospital stay (<a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>); within 90 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>); or was unknown (<a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>). The remaining studies reported data at 28 or 30 days. </p> <p>We found little or no difference in the number of participants who had died from any cause at the end of follow‐up according to whether fluid resuscitation was with albumin or FFP compared to a crystalloid (RR 0.98, 95% CI 0.92 to 1.06; 13,047 participants; 20 studies; I² = 7%; <a href="./references#CD000567-fig-0020" title="">Analysis 4.1</a>). </p> <p>We generated a funnel plot to assess risk of publication bias. One study was an outlier in this plot, which we could not explain, but, because the only outlier was a small study from 1978, we did not believe this was evidence of a high risk of publication bias. See <a href="#CD000567-fig-0006">Figure 6</a>. </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as moderate. We downgraded the evidence by one level for study limitations because some studies had unclear risk of selection bias, and because, for many studies, we were unable to assess risk of selective reporting bias due to lack of prospective clinical trials registration. See <a href="./full#CD000567-tbl-0004">summary of findings Table 4</a>. </p> </section> <section id="CD000567-sec-0134"> <h5 class="title">All‐cause mortality within 90 days</h5> <p>Eleven studies measured mortality within 90 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>). We did not include outcome data from one study (<a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>), as mortality data were reported overall, not by group (12 of 50 participants died). </p> <p>We included mortality data in this analysis in which the time point was: within 24 hours (<a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>); within seven days (<a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>); within 30 days (<a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>); and within 90 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>). </p> <p>We found little or no difference in the number of participants who died from any cause within 90 days according to whether fluid resuscitation was with albumin or FFP compared to a crystalloid (RR 0.98, 95% CI 0.92 to 1.04; 12,492 participants; 10 studies; I² = 0%; <a href="./references#CD000567-fig-0021" title="">Analysis 4.2</a>). </p> <p>We generated a funnel plot to assess risk of publication bias. One study was an outlier in this plot, which we could not explain; we could not be certain whether this indicated risk of publication bias. </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as moderate. We downgraded the evidence by one level for study limitations because some studies had unclear risk of selection bias, and because, for many studies, we were unable to assess risk of selective reporting bias due to lack of prospective clinical trials registration. See <a href="./full#CD000567-tbl-0004">summary of findings Table 4</a>. </p> </section> <section id="CD000567-sec-0135"> <h5 class="title">All‐cause mortality within 30 days</h5> <p>Eleven studies measured mortality within 30 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>). We did not include outcome data from one study (<a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>), as mortality data were reported overall, not by group (12 of 50 participants died). </p> <p>We included mortality data in this analysis in which the time point was: within 24 hours (<a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>); within seven days (<a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>); or within 28 or 30 days (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>; <a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>). </p> <p>We found little or no difference in the number of participants who died from any cause within 30 days according to whether fluid resuscitation was with albumin or FFP compared to a crystalloid (RR 0.99, 95% CI 0.93 to 1.06; 12,506 participants; 10 studies; I² = 0%; <a href="./references#CD000567-fig-0022" title="">Analysis 4.3</a>). </p> <p>We generated a funnel plot to assess risk of publication bias. One study was an outlier in this plot, which we could not explain; we could not be certain whether this indicated risk of publication bias. </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as moderate. We downgraded the evidence by one level for study limitations because some studies had unclear risk of selection bias, and because, for many studies, we were unable to assess risk of selective reporting bias due to lack of prospective clinical trials registration. See <a href="./full#CD000567-tbl-0004">summary of findings Table 4</a>. </p> </section> <section id="CD000567-sec-0136"> <h5 class="title">Transfusion of blood products</h5> <p>Four studies reported outcome data for transfusion of blood products (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>). </p> <p>One study, which allowed type of colloid or crystalloid to be at the discretion of the clinician, reported the number of participants who received a blood product, but these data were not reported according to type of colloid received (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>). We did not include these data in analysis of albumin or FFP because the types of colloid used were either hydroxyethyl starch, gelatins, or albumin. We included data for transfusion of blood products for <a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> in <a href="#CD000567-tbl-0006">Table 2</a>; we noted little or no difference between groups in the need for blood products according to whether participants were given a colloid (hydroxyethyl starch, gelatins, or albumin) or a crystalloid. </p> <p>We found little or no difference in the number of participants who had transfusion of blood products according to whether fluid resuscitation was with albumin or FFP compared to a crystalloid (RR 1.31, 95% CI 0.95 to 1.80; 290 participants; 3 studies; I² = 0%; <a href="./references#CD000567-fig-0023" title="">Analysis 4.4</a>). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as very low. We downgraded the evidence by two levels for study limitations because some studies had unclear risk of selection bias, and we noted baseline imbalances in one study. We downgraded by one level for imprecision because analysis included few studies with few participants. See <a href="./full#CD000567-tbl-0004">summary of findings Table 4</a>. </p> </section> <section id="CD000567-sec-0137"> <h5 class="title">Renal replacement therapy</h5> <p>Four studies collected outcome data related to renal replacement therapy (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>). </p> <p>One study, which allowed type of colloid or crystalloid to be at the discretion of the clinician, reported the number of participants who required renal replacement therapy, but these data were not reported according to type of colloid received (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>). We did not include these data in analysis of albumin or FFP because the types of colloid used were either hydroxyethyl starch, gelatins, or albumin. We included data for renal replacement therapy for <a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> in <a href="#CD000567-tbl-0006">Table 2</a>; we noted little or no difference between groups in the need for renal replacement therapy according to type of fluid. The study report for <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a> was an abstract that stated that renal replacement therapy was a secondary outcome, but outcome data were not reported in the abstract. Data in <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a> were reported for a smaller subgroup of participants who had severe sepsis; we included these data in the analysis. </p> <p>We noted little or no difference according to type of fluid resuscitation in the number of participants who received renal replacement therapy (RR 1.11, 95% CI 0.96 to 1.27; 3028 participants; 2 studies; I² = 0%; <a href="./references#CD000567-fig-0024" title="">Analysis 4.5</a>). </p> <p>We used GRADE, and assessed the level of certainty of the evidence for this outcome as low. We downgraded the evidence by two levels for study limitations because we noted baseline imbalances and because we could not be certain whether participants in the crystalloids group in one study may have received colloids. See <a href="./full#CD000567-tbl-0004">summary of findings Table 4</a>. </p> </section> <section id="CD000567-sec-0138"> <h5 class="title">Adverse events (allergic reaction, itching, rashes)</h5> <p>One study reported incidences of allergic reaction (<a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a>). We used RevMan 5 to calculate an effect estimate (<a href="./references#CD000567-bbs2-0140" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>); we noted little or no difference between groups in allergic reactions (RR 0.75, 95% CI 0.17 to 3.33; 2097 participants; 1 study; <a href="#CD000567-tbl-0006">Table 2</a>). </p> <p>We used the GRADE approach to downgrade the certainty of the evidence to very low. We downgraded by one level for study limitations because we were unable to assess the risk of selective outcome reporting bias since the study authors did not report clinical trials registration. We downgraded by two levels because evidence was from one study with few events. See <a href="./full#CD000567-tbl-0004">summary of findings Table 4</a>. </p> </section> </section> <section id="CD000567-sec-0139"> <h4 class="title">Subgroup analysis</h4> <section id="CD000567-sec-0140"> <h5 class="title">Tonicity of crystalloid solution</h5> <p>We found that many studies did not report the solution in which the colloid was suspended. One study used albumin with an isotonic crystalloid (suspended in normal saline) versus an isotonic crystalloid (normal saline) (<a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>), and one study used albumin with an isotonic crystalloid (normal saline) versus a hypertonic crystalloid (Ringer's lactate) (<a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>). One study used albumin with a hypertonic crystalloid (hypertonic saline) versus a hypertonic crystalloid (Ringer's lactate) (<a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>), and five studies used albumin with a hypertonic crystalloid (Ringer's lactate) versus a hypertonic crystalloid (Ringer's lactate) (<a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>). We found insufficient studies to conduct meaningful subgroup analysis. </p> </section> </section> <section id="CD000567-sec-0141"> <h4 class="title">Sensitivity analysis</h4> <section id="CD000567-sec-0142"> <h5 class="title">Studies at high or unclear risk of selection bias</h5> <p>We excluded two studies that we judged to have high risk of selection bias (<a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>), and nine studies that we judged to have unclear risk of selection bias from analysis of mortality (<a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a>; <a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a>; <a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a>; <a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>). This did not alter interpretation of the effect for all‐cause mortality (at end of follow‐up), with little or no difference between groups (RR 0.98, 95% CI 0.91 to 1.04; 12,111 participants; 9 studies; I² = 0%). </p> </section> <section id="CD000567-sec-0143"> <h5 class="title">Studies in which some participants in the crystalloid group were given, or may have been given, additional colloids </h5> <p>Some studies were at risk of bias because some participants in the crystalloid group were given, or may have been given, additional colloids. We excluded three studies from analysis of mortality (<a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>; <a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>). This did not alter interpretation of the effect for all‐cause mortality (at end of follow‐up), with little or no difference between groups (RR 0.96, 95% CI 0.88 to 1.04; 4970 participants; 17 studies; I² = 0%). </p> </section> <section id="CD000567-sec-0144"> <h5 class="title">Alternative meta‐analytical effects model (fixed‐effect)</h5> <p>Using the alternative meta‐analytical effects model (fixed‐effect) did not alter interpretation of the effect for all‐cause mortality (at end of follow‐up), with little or no difference between groups (RR 0.99, 95% CI 0.93 to 1.05; 13,047 participants; 20 studies; I² = 7%). </p> </section> <section id="CD000567-sec-0145"> <h5 class="title">Studies with discrepancies in data</h5> <p>We noted a discrepancy in mortality outcome data in different published reports for <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>. In sensitivity analysis, we used alternative data reported in a later publication, Lucas 1980, which is cited as part of <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>. This did not alter interpretation of the effect for all‐cause mortality (at end of follow‐up), with little or no difference between groups (RR 0.98, 95% CI 0.92 to 1.04; 13,047 participants; 20 studies; I² = 0%). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000567-sec-0146" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000567-sec-0146">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000567-sec-0208">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000567-sec-0146"></div> <section id="CD000567-sec-0147"> <h3 class="title" id="CD000567-sec-0147">Summary of main results</h3> <p>We included 69 studies comparing colloids (suspended in any solution) versus crystalloids (isotonic or hypertonic) in critically ill people who required fluid resuscitation. In addition, we identified seven studies that are awaiting classification (two studies were published only as abstracts with insufficient information, three completed studies are listed on clinical trials register sites without publication of full reports, and two studies require translation from Russian), and three ongoing studies. </p> <p>We reported four comparisons for each type of colloid (starches; dextrans; gelatins; and albumin or FFP) versus crystalloids. We collected outcome data for all‐cause mortality at end of follow‐up, within 90 days, and within 30 days; need for transfusion of blood products; need for renal replacement therapy; and adverse events (allergic reaction, itching, and rashes). </p> <p>We found moderate‐certainty evidence that there is probably little or no difference in all‐cause mortality at the end of follow‐up, within 90 days, or within 30 days between colloids (which are: starches; dextrans; or albumin or FFP) or crystalloids for fluid resuscitation. We found low‐certainty evidence that there may be little or no difference in all‐cause mortality at the end of follow‐up, within 90 days, or within 30 days between gelatins or crystalloids for fluid resuscitation. </p> <p>We found moderate‐certainty evidence that using starches probably slightly increases the need for transfusion of blood products. Studies comparing dextrans, gelatins, and albumin or FFP to crystalloids, found little or no difference in the need for transfusion of blood products but certainty of this evidence was very low. </p> <p>We found moderate‐certainty evidence that using starches probably slightly increases the need for renal replacement therapy. We found low‐certainty evidence from two studies that albumin or FFP versus crystalloids may make little or no difference to the need for renal replacement therapy. We could not use data from renal replacement therapy from one study of gelatins because data were not reported by type of colloid solution, and no studies of dextrans measured this outcome. </p> <p>Evidence for adverse events (allergic reactions, itching, or rashes) is very low certainty because studies often did not report events. For starches, we found little or no difference between either fluid group in allergic reactions in three studies, but we found more incidences of itching and rashes in two studies. For dextrans, gelatins, and for albumin or FFP, we found little or no difference between groups in allergic reactions. </p> </section> <section id="CD000567-sec-0148"> <h3 class="title" id="CD000567-sec-0148">Overall completeness and applicability of evidence</h3> <p>We identified 69 studies with 30,020 participants who were undergoing fluid resuscitation for conditions that indicated that they were critically ill. The conditions being managed with fluid resuscitation varied, and settings also varied; 10 studies were based in an out‐of‐hospital setting. </p> <p>All studies compared colloids versus crystalloids. We found 28 studies using starch solutions, 20 studies using dextran solutions, seven studies using gelatins, and 22 studies using albumin or FFP. Some study authors did not report the specific nature of the solution the colloid was suspended in, and other studies reported the use of either an isotonic or hypertonic crystalloid suspension solution. Because of the different use of crystalloid solutions for this purpose, and the different compositions of the comparative crystalloids, we could not be certain whether comparisons by type of colloid were always equivalent. We were unable to perform meaningful subgroup analysis for most types of colloids because of limitations in reporting of suspension solutions. Also, individual study protocols for the concentration, quantity, and timing of administration of fluids varied. </p> <p>We also noted that studies ranged in date of publication from 1977 to 2016, and, while we did not consider the potential influence of date on our results, it is possible that changes in management of critically ill people may mean that some study data may not be generalisable to the current clinical context. </p> </section> <section id="CD000567-sec-0149"> <h3 class="title" id="CD000567-sec-0149">Quality of the evidence</h3> <p>We used GRADE to consider the effect of study limitations on our outcomes. We found many studies did not report adequate methods of randomisation or allocation concealment, and we could not be certain of the risk of selection bias. We noted that some studies did not report whether clinicians were blinded to the type of study fluids they were giving to participants, or whether outcome assessors were blinded. However, we did not consider risk of performance or detection bias to be likely for mortality, and we did not believe lack of performance or detection bias for our remaining outcomes (transfusion of blood products, renal replacement therapy, or adverse events) were important reasons to downgrade the evidence for this review. We noted that few studies were registered prospectively with clinical trials registers, and although many studies predate the expectation of clinical trials registration, we could not rule out the risk of selective outcome reporting in this review. We included some studies in which some participants in the crystalloid groups were given, or may have been given, additional colloids. Because we could not be certain of the influence of this additional colloid use on the results, we judged these studies to have a high risk of bias and downgraded the certainty of the evidence accordingly. We downgraded the certainty of the evidence for some of our outcomes because of imprecision; for these outcomes, we found evidence from few studies. </p> </section> <section id="CD000567-sec-0150"> <h3 class="title" id="CD000567-sec-0150">Potential biases in the review process</h3> <p>We conducted a thorough search and used two review authors independently to assess study eligibility, extract data, and assess risk of bias in included studies, and believe that this reduced potential bias in the review process. However, we made a post hoc decision to change criteria for considering studies in this review update from the previous version of the review (<a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a>). This decision led to the exclusion of 36 previously included studies. Our intention was to create a more focused review, with a more comparable participant group, once we had excluded participants scheduled for a wide range of elective surgical procedures; we acknowledge that the exclusion of this large number of studies may also have influenced a change in results since the previous review publication. </p> <p>We included a number of studies in the review in which participants in the crystalloid group may have received additional colloids. It is possible that our decision to include these studies in our primary analysis may have introduced clinical differences, or bias, between studies, and subsequently influenced our results. We assessed this decision during sensitivity analysis for our primary outcome (all‐cause mortality (at end of follow‐up)) and found that the interpretation of our effect estimates was the same regardless of whether we included these studies. However, we noted that in our comparison of starches versus crystalloids, inclusion of these studies increased statistical heterogeneity (I² = 34%); we did not explore this further in the review. </p> <p>We included additional outcomes in this review; we intended to explore other effects of colloids and crystalloids for fluid resuscitation. We limited these additional outcomes to need for blood transfusion, need for renal replacement therapy, and three possible adverse events (allergic reactions, itching, and rashes). We acknowledge that our review is limited to only eight outcomes in four types of colloid solutions, and therefore does not explore all the potential risks and benefits of using either colloids or crystalloids in the critically ill setting. </p> <p>The review does not include seven studies that are awaiting classification (<a href="./references#CD000567-bbs2-0103" title="Abd El HalimMA , Elsaid HafezMH , MoktarAM , EladawyA , ElazizyHM . Impact of gelatins on perfusion of microcirculatory blood flow in patient with septic shock. In: 29th Annual Congress of the European Society of Intensive Care Medicine (ESICM), 2016 Oct 1‐5; Milan (Italy). Intensive Care Medicine Experimental2016. ">Halim 2016</a>; <a href="./references#CD000567-bbs2-0101" title="BulanovAI , GorodetskiiVM , ShulutkoEM , Vasil'evSA , OrelEB , MalofeevVN , et al. Effect of different colloid volume‐replacing solutions on a changed hemostasis system. Anesteziologiia i Reanimatologiia2004;2:25‐30. [PUBMED: 15206272] ">Bulanov 2004</a>; <a href="./references#CD000567-bbs2-0102" title="CharpentierJ , MiraJ‐P . Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study. Intensive Care Medicine2011;37(Suppl 1):S115. ">Charpentier 2011</a>; <a href="./references#CD000567-bbs2-0104" title='NCT00890383 . Colloids in severe trauma [Colloids in severe trauma: a multi‐center pilot study of "crystalloid only" or "crystalloid + colloid" volume resuscitation in trauma patients (CIST)]. clinicaltrials.gov/ct2/show/record/NCT00890383 (first received 29 April 2009). '>NCT00890383</a>; <a href="./references#CD000567-bbs2-0105" title="NCT01337934 . Ringer versus albumin in septic patients: a randomized controlled clinical trial [Lactated Ringer versus albumin in early sepsis therapy (RASP)]. clinicaltrials.gov/ct2/show/NCT01337934 (first received 13 April 2011). ">NCT01337934</a>; <a href="./references#CD000567-bbs2-0106" title="NCT02064075 . The mortality and changes in quality of life of patients suffering from SAH with different hydration strategies [Phase 4 prospective, randomized, blinded study on the effect of different hydration strategies on mortality and changes in quality of life of patients suffering from subarachnoid haemorrhage]. clinicaltrials.gov/ct2/show/record/NCT02064075 (first received 17 February 2014). ">NCT02064075</a>; <a href="./references#CD000567-bbs2-0107" title="ProtsenkoDN , LeidermanIN , Grigor'evEV , KokarevEA , LevitAL , Gel'fandBR . Evaluation of the effectiveness and safety of synthetic colloid solutions in the treatment of severe abdominal sepsis: a randomized comparative study. Anesteziologiia i Reanimatologiia2009;5:9‐13. [PUBMED: 19938709] ">Protsenko 2009</a>). We did not seek translation of the full study reports for four studies that were reported in Chinese (<a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a>); our judgements and data were limited to information available in the abstract, or the tables. </p> </section> <section id="CD000567-sec-0151"> <h3 class="title" id="CD000567-sec-0151">Agreements and disagreements with other studies or reviews</h3> <p>The results of this review differ from those of the previous version (<a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a>), which found an increase in mortality when participants were given starches rather than crystalloids for fluid resuscitation. For this 2018 update, because of changes in the criteria for considering studies in this review, we excluded studies of elective surgical patients. However, because of a decision to include additional outcomes, we re‐ran searches from database inception and included 27 new studies in the review, 13 of which compared starches to crystalloids. Our moderate‐certainty evidence, which demonstrates little or no difference in all‐cause mortality for starches, includes a large number of studies, but we cannot be certain whether the difference in our results is because we excluded elective surgical patients. Results for mortality for dextrans, gelatins, and albumin or FFP were the same as those in <a href="./references#CD000567-bbs2-0146" title="PerelP , RobertsI , KerK . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD000567.pub6] ">Perel 2013</a>. </p> <p>Whilst other systematic reviews may concentrate on particular types of colloids, or particular participant groups, our findings for mortality appear relatively comparable. <a href="./references#CD000567-bbs2-0127" title="HeB , XuB , XuX , LiL , RenR , ChenZ , et al. Hydroxyethyl starch versus other fluids for non‐septic patients in the intensive care unit: a meta‐analysis of randomized controlled trials. Critical Care2015;19:92. [PUBMED: 25886952] ">He 2015</a> found no increase in mortality with hydroxyethyl starch for non‐septic patients in the intensive care unit, as did <a href="./references#CD000567-bbs2-0126" title="HaaseN , PernerA , HenningsLI , SiegemundM , LauridsenB , WetterslevM , et al. Hydroxyethyl starch 130/0.38‐0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta‐analysis and trial sequential analysis. BMJ (Clinical Research Ed.)2013;346:f839. [PUBMED: 23418281] ">Haase 2013</a> for patients with sepsis. However, <a href="./references#CD000567-bbs2-0120" title="GattasDJ , DanA , MyburghJ , BillotL , LoS , FinferS . Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Medicine2013;39(4):558‐68. [PUBMED: 23407978] ">Gattas 2013</a>, which included participants undergoing surgical procedures, reported a non‐statistically significant increase in mortality when starches were used. In reviews of other colloids, <a href="./references#CD000567-bbs2-0115" title="deCrescenzoC , GorouhiF , SalcedoES , GalanteJM . Prehospital hypertonic fluid resuscitation for trauma patients: a systematic review and meta‐analysis. The Journal of Trauma and Acute Care Surgery2017;82(5):956‐62. [PUBMED: 28257392] ">de Crescenzo 2017</a> found no effect on mortality of trauma patients treated in a prehospital setting with dextrans; <a href="./references#CD000567-bbs2-0138" title="QureshiSH , RizviSI , PatelNN , MurphyGJ . Meta‐analysis of colloids versus crystalloids in critically ill, trauma and surgical patients. The British Journal of Surgery2016;103(1):14‐26. [PUBMED: 26522616] ">Qureshi 2016</a> found no increase in mortality of critically ill, trauma, and surgical patients with any type of colloid; and <a href="./references#CD000567-bbs2-0118" title="EljaiekR , HeylbroeckC , DuboisMJ . Albumin administration for fluid resuscitation in burn patients: a systematic review and meta‐analysis. Burns2017;43(1):17‐24. [PUBMED: 27613476] ">Eljaiek 2017</a> found no difference in mortality of burn patients who were given albumin for fluid replacement. </p> <p>Also, we found some comparable results for renal replacement and blood transfusion. <a href="./references#CD000567-bbs2-0126" title="HaaseN , PernerA , HenningsLI , SiegemundM , LauridsenB , WetterslevM , et al. Hydroxyethyl starch 130/0.38‐0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta‐analysis and trial sequential analysis. BMJ (Clinical Research Ed.)2013;346:f839. [PUBMED: 23418281] ">Haase 2013</a> and <a href="./references#CD000567-bbs2-0120" title="GattasDJ , DanA , MyburghJ , BillotL , LoS , FinferS . Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Medicine2013;39(4):558‐68. [PUBMED: 23407978] ">Gattas 2013</a> found that more participants given starches required renal replacement therapy, whilst <a href="./references#CD000567-bbs2-0126" title="HaaseN , PernerA , HenningsLI , SiegemundM , LauridsenB , WetterslevM , et al. Hydroxyethyl starch 130/0.38‐0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta‐analysis and trial sequential analysis. BMJ (Clinical Research Ed.)2013;346:f839. [PUBMED: 23418281] ">Haase 2013</a> also found this effect with starches for transfusion of red blood cells. Similarly, <a href="./references#CD000567-bbs2-0138" title="QureshiSH , RizviSI , PatelNN , MurphyGJ . Meta‐analysis of colloids versus crystalloids in critically ill, trauma and surgical patients. The British Journal of Surgery2016;103(1):14‐26. [PUBMED: 26522616] ">Qureshi 2016</a> found an increase in acute kidney failure requiring renal replacement that was more pronounced for those who were given fluid resuscitation with starches, but this result was not replicated by <a href="./references#CD000567-bbs2-0127" title="HeB , XuB , XuX , LiL , RenR , ChenZ , et al. Hydroxyethyl starch versus other fluids for non‐septic patients in the intensive care unit: a meta‐analysis of randomized controlled trials. Critical Care2015;19:92. [PUBMED: 25886952] ">He 2015</a>, who found no difference in incidence of renal replacement therapy with use of starches. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000567-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD000567-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. We did not make judgements for studies that did not report outcomes of interest in the review, which are indicated by blank spaces" data-id="CD000567-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. We did not make judgements for studies that did not report outcomes of interest in the review, which are indicated by blank spaces </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study. We did not make judgements for studies that did not report outcomes of interest in the review, which are indicated by blank spaces" data-id="CD000567-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. We did not make judgements for studies that did not report outcomes of interest in the review, which are indicated by blank spaces </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison 1. Starches vs crystalloid, outcome: 1.1 mortality at end of follow‐up" data-id="CD000567-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison 1. Starches vs crystalloid, outcome: 1.1 mortality at end of follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison 2. Dextrans vs crystalloid, outcome: 2.1 mortality at end of follow‐up" data-id="CD000567-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison 2. Dextrans vs crystalloid, outcome: 2.1 mortality at end of follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison 4. Albumin and FFP vs crystalloid, outcome: 4.1 mortality at end of follow‐up" data-id="CD000567-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison 4. Albumin and FFP vs crystalloid, outcome: 4.1 mortality at end of follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Starches vs crystalloid, Outcome 1 Mortality at end of follow‐up." data-id="CD000567-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Starches vs crystalloid, Outcome 1 Mortality at end of follow‐up.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Starches vs crystalloid, Outcome 2 Mortality within 90 days." data-id="CD000567-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Starches vs crystalloid, Outcome 2 Mortality within 90 days.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Starches vs crystalloid, Outcome 3 Mortality within 30 days." data-id="CD000567-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Starches vs crystalloid, Outcome 3 Mortality within 30 days.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Starches vs crystalloid, Outcome 4 Transfusion of blood product." data-id="CD000567-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Starches vs crystalloid, Outcome 4 Transfusion of blood product.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Starches vs crystalloid, Outcome 5 Renal replacement therapy." data-id="CD000567-fig-0011" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Starches vs crystalloid, Outcome 5 Renal replacement therapy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Starches vs crystalloid, Outcome 6 Adverse event: allergic reaction." data-id="CD000567-fig-0012" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Starches vs crystalloid, Outcome 6 Adverse event: allergic reaction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Starches vs crystalloid, Outcome 7 Adverse event: itching." data-id="CD000567-fig-0013" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Starches vs crystalloid, Outcome 7 Adverse event: itching.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Starches vs crystalloid, Outcome 8 Adverse event: rash." data-id="CD000567-fig-0014" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Starches vs crystalloid, Outcome 8 Adverse event: rash.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Dextrans vs crystalloid, Outcome 1 Mortality at end of follow‐up." data-id="CD000567-fig-0015" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Dextrans vs crystalloid, Outcome 1 Mortality at end of follow‐up.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Dextrans vs crystalloid, Outcome 2 Mortality within 90 days and 30 days." data-id="CD000567-fig-0016" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Dextrans vs crystalloid, Outcome 2 Mortality within 90 days and 30 days.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Dextrans vs crystalloid, Outcome 3 Transfusion of blood products." data-id="CD000567-fig-0017" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Dextrans vs crystalloid, Outcome 3 Transfusion of blood products.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Dextrans vs crystalloid, Outcome 4 Adverse events: allergic reaction." data-id="CD000567-fig-0018" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Dextrans vs crystalloid, Outcome 4 Adverse events: allergic reaction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Gelatins vs crystalloid, Outcome 1 Mortality at end of follow‐up." data-id="CD000567-fig-0019" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Gelatins vs crystalloid, Outcome 1 Mortality at end of follow‐up.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-004-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Albumin or FFP vs crystalloid, Outcome 1 Mortality at end of follow‐up." data-id="CD000567-fig-0020" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Albumin or FFP vs crystalloid, Outcome 1 Mortality at end of follow‐up.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Albumin or FFP vs crystalloid, Outcome 2 Mortality within 90 days." data-id="CD000567-fig-0021" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Albumin or FFP vs crystalloid, Outcome 2 Mortality within 90 days.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Albumin or FFP vs crystalloid, Outcome 3 Mortality within 30 days." data-id="CD000567-fig-0022" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Albumin or FFP vs crystalloid, Outcome 3 Mortality within 30 days.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Albumin or FFP vs crystalloid, Outcome 4 Transfusion of blood product." data-id="CD000567-fig-0023" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Albumin or FFP vs crystalloid, Outcome 4 Transfusion of blood product.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Albumin or FFP vs crystalloid, Outcome 5 Renal replacement therapy." data-id="CD000567-fig-0024" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Albumin or FFP vs crystalloid, Outcome 5 Renal replacement therapy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000567-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/urn:x-wiley:14651858:media:CD000567:CD000567-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_t/tCD000567-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Dextrans vs crystalloid: subgroup by tonicity of crystalloid, Outcome 1 All‐cause mortality at end of follow‐up." data-id="CD000567-fig-0025" src="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Dextrans vs crystalloid: subgroup by tonicity of crystalloid, Outcome 1 All‐cause mortality at end of follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/media/CDSR/CD000567/image_n/nCD000567-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000567-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Starches compared to crystalloid for fluid resuscitation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Starches compared to crystalloid for fluid resuscitation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> critically ill people requiring fluid resuscitation<br/> <b>Setting:</b> in hospital, in Algeria, Argentina, Belgium, Brazil, Canada, China, France, Germany, India, the Netherlands, Phillipines, South Africa, Switzerland, Tunisia, the UK, USA and Vietnam<br/> <b>Intervention:</b> starches to include hydroxyethyl starch, hetastarch, and pentastarch<br/> <b>Comparison:</b> crystalloids to include normal saline, hypertonic saline, Ringer's lactate and Ringer's acetate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with crystalloids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with starches</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (at end of follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.97<br/> (0.86 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>11,177<br/> (24 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>We excluded data from 1 study because we could not be certain whether it accounted for attrition </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>233 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>226 per 1000<br/> (201 to 254) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (at 90 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.01<br/> (0.90 to 1.14) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>10,415<br/> (15 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>We excluded data from 1 study because we could not be certain whether it accounted for attrition </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>238 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>241 per 1000<br/> (214 to 272) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All‐cause mortality (within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/> (0.90 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>10,135<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We excluded data from 1 study because we could not be certain whether it accounted for attrition </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>191 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000<br/> (172 to 208) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Transfusion of blood products</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.19<br/> (1.02 to 1.39) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1917<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only starches; we noted little or no difference between groups in need for transfusion of blood products in this study </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>299 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>356 per 1000<br/> (305 to 416) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Renal replacement therapy</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.30<br/> (1.14 to 1.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8527<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only starches; we noted little or no difference between groups in need for renal replacement therapy in this study </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>106 per 1000<br/> (93 to 121) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="9" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Allergic reaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="9" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="9" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 2.59 (0.27 to 24.91)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>7757 (3 studies)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Itching</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.38 (1.05 to 1.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>6946 (2 studies)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>26 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>35 per 1000</p> <p>(27 to 46)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Rashes</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.61 (0.90 to 2.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>7007 (2 studies)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>5 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>9 per 1000</p> <p>(5 to 15)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI</b> : confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for study limitations; some included studies had unclear risk of selection bias, one small study had a high risk of selection bias, and we were often unable to assess risk of selective reporting bias because many included studies did not have prospective clinical trials registration.<br/> <sup>b</sup>We downgraded by one level for study limitations; some included studies had unclear risk of selection bias, and we were often unable to assess risk of selective reporting bias because many included studies did not have prospective clinical trials registration.<br/> <sup>c</sup>We downgraded by one level for study limitations; some included studies had unclear risk of selection bias, and we were unable to assess risk of selective reporting bias in some studies because they did not have prospective clinical trials registration. We downgraded by two levels for imprecision; few of our included studies reported data for these outcomes. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Starches compared to crystalloid for fluid resuscitation in critically ill patients</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000567-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dextrans compared to crystalloid for fluid resuscitation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dextrans compared to crystalloid for fluid resuscitation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> critically ill people requiring fluid resuscitation<br/> <b>Setting:</b> in hospital, or out of hospital, in Brazil, Canada, Denmark, Mexico, Sweden, UK, USA and Vietnam<br/> <b>Intervention:</b> dextrans<br/> <b>Comparison:</b> crystalloids to include: normal saline, hypertonic saline, Ringer's lactate, Ringer's acetate, and unspecified types of crystalloids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with crystalloids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with dextrans</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (at end of follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.99<br/> (0.88 to 1.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>4736<br/> (19 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>237 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>235 per 1000<br/> (209 to 263) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (within 90 days and within 30 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.99<br/> (0.87 to 1.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>3353<br/> (10 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>258 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>256 per 1000<br/> (225 to 289) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Transfusion of blood products</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.92</p> <p>(0.77 to 1.10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1272</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>332 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>305 per 1000</p> <p>(255 to 365)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Renal replacement therapy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="9" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Allergic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="9" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 6.00</p> <p>(0.25 to 144.93)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>739</p> <p>(4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="8" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Itching</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Rashes</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for study limitations; some included studies had unclear risk of selection bias and we were often unable to assess risk of selective reporting bias because many included studies did not have prospective clinical trials registration.<br/> <sup>b</sup>We downgraded by two levels for study limitations; we noted in two studies that some participants were given additional colloids in the crystalloid group, and in one study we could not be certain whether some participants in the crystalloids groups also received up to 2000 mL colloid resuscitation prior to randomisation. In addition, we were unable to assess risk of selective reporting bias because of lack of prospective clinical trials registration in each study. We downgraded by one level for imprecision; evidence was from three studies.<br/> <sup>c</sup>We downgraded by one level for study limitations; one study had an unclear risk of selection bias and we were unable to assess risk of selective outcome reporting bias in all studies. We downgraded by two levels for imprecision because evidence was from few studies with few events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Dextrans compared to crystalloid for fluid resuscitation in critically ill patients</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000567-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Gelatins compared to crystalloid for fluid resuscitation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Gelatins compared to crystalloid for fluid resuscitation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> critically ill people requiring fluid resuscitation<br/> <b>Setting:</b> in hospital, in Algeria, France, Germany, India, South Africa, Taiwan, Tunisia and Vietnam<br/> <b>Intervention:</b> gelatins<br/> <b>Comparison:</b> crystalloids to include normal saline and Ringer's lactate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with crystalloids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with gelatins</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (at end of follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.89<br/> (0.74 to 1.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1698<br/> (6 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝</p> <p>Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>301 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>268 per 1000<br/> (223 to 325) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (within 90 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.89 (0.73 to 1.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1388</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝</p> <p>Low<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>334 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>298 per 1000</p> <p>(244 to 364)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All‐cause mortality (within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.92 (0.74 to 1.16)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1388</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>266 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>244 per 1000</p> <p>(197 to 308)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Transfusion of blood products</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 5.89</p> <p>(0.24 to 142.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>167</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>We calculated an effect estimate for one small study, with one event in the gelatin group. </p> <p>1 study reported transfusion of blood products but data were not reported by group.</p> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only gelatins. We noted little or no difference between groups in need for transfusion of blood products </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Renal replacement therapy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only gelatins. We noted little or no difference between groups in need for renal replacement therapy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Allergic reaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="6" valign=""> <p>We calculated an effect estimate for one small study, with five incidences of allergic reactions in the gelatin group </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 21.61 (1.22 to 384.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>167</p> <p>(1 study)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Itching</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Rashes</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for study limitations; risk of selection bias was unclear in some studies, and because we were unable to assess risk of selective outcome reporting bias in some studies. We downgraded by one level for imprecision; evidence was from few studies, and we could not be certain of time points for data collection.<br/> <sup>b</sup>We downgraded by two levels for imprecision; evidence was from a single study.<br/> <sup>c</sup>We downgraded by one level for study limitations; we were unable to assess risk of selective outcome reporting bias due to lack of prospective clinical trials registration, and some participants in the crystalloid groups also received colloids. We downgraded two levels for imprecision; evidence was from a single small study with very few events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Gelatins compared to crystalloid for fluid resuscitation in critically ill patients</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000567-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Albumin and fresh frozen plasma compared to crystalloid for fluid resuscitation in critically ill patients</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Albumin and fresh frozen plasma compared to crystalloid for fluid resuscitation in critically ill patients</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> critically ill people requiring fluid resuscitation<br/> <b>Setting:</b> in hospital and out of hospital, in Algeria, Brazil, Canada, France, Germany, Kenya, India, Italy, Tanzania, Tunisia, Uganda and USA<br/> <b>Intervention:</b> albumin and fresh frozen plasma<br/> <b>Comparison:</b> crystalloids to include: normal saline, hypertonic saline, Ringer's lactate, electrolytes, and unspecified types of crystalloids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with crystalloids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with albumin and FFP</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (at end of follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.98<br/> (0.92 to 1.06) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>13,047<br/> (20 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>One study also reported mortality but not by group, and so could not be included in analysis </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>254 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>249 per 1000<br/> (234 to 270) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>All‐cause mortality (within 90 days)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.98<br/> (0.92 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>12,492<br/> (10 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>One study also reported mortality but not by group, and so could not be included in analysis </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>259 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>254 per 1000<br/> (239 to 270) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All‐cause mortality (within 30 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/> (0.93 to 1.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>12,506<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝</p> <p>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study also reported mortality but not by group, and so could not be included in analysis </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>234 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>231 per 1000<br/> (217 to 248) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Transfusion of blood products</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.31<br/> (0.95 to 1.80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>290<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only albumins or FFP; we noted little or no difference between groups in need for transfusion of blood products </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>281 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>368 per 1000<br/> (267 to 506) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Renal replacement therapy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>201 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>223 per 1000</p> <p>(193 to 255)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.11 (0.96 to 1.27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3028</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> <p>Low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One study stated that renal replacement data were measured but it was not reported in the study report (abstract) </p> <p>1 study included different types of colloids (HES, gelatins, or albumin). We did not include this in analysis because study authors did not report data for only albumin and FFP. We noted little or no difference between groups in need for renal replacement therapy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Allergic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign=""> <p>⊕⊝⊝⊝</p> <p>Very low<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="7" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.75 (0.17 to 3.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2097</p> <p>(1 study)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>4 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>3 per 1000</p> <p>(1 to 13)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Itching</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign=""> <p>Rashes</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>FFP:</b> fresh frozen plasma <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for study limitations; some included studies had unclear risk of selection bias, and we were often unable to assess risk of selective reporting bias because many included studies did not have prospective clinical trials registration.<br/> <sup>b</sup>We downgraded by two levels for study limitations; some studies had unclear risk of selection bias, and we noted baseline imbalances in one study. We downgraded by one level for imprecision because analysis included few studies with few participants.<br/> <sup>c</sup>We downgraded by two levels for study limitations; we noted baseline imbalances and we could not be certain how many participants in the crystalloids group may have received additional colloids.<br/> <sup>d</sup>We downgraded by one level for study limitations; we were unable to assess risk of selective reporting bias because the included study did not appear to have prospective clinical trials registration. We downgraded by two levels for imprecision; evidence was from a single study with few events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Albumin and fresh frozen plasma compared to crystalloid for fluid resuscitation in critically ill patients</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD000567-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of participant conditions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participant condition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Admission to an ICU with any condition (which included trauma, sepsis, ARDS, head injury) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0019" title="BellomoR , MorimatsuH , PresneillJ , FrenchC , ColeL , StoryD , et al. Effects of saline or albumin resuscitation on standard coagulation tests. Critical Care and Resuscitation2009;11(4):250‐6. [PUBMED: 20001872] FinferS , BellomoR , BoyceN , FrenchJ , MyburghJ , NortonR , et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine2004;350(22):2247‐56. [15163774] FinferS , BellomoR , McEvoyS , LoSK , MyburghJ , NealB , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;7577:1044. [PUBMED: 17040925] FinferS , MyburghJ , NortonR , CooperDJ , MacMahonS , PetoR , et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Medicine2011;37(1):86‐96. [PUBMED: 20924555] MyburghJ , CooperDJ , FinferS , BellomoR , NortonR , BishopN , et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New England Journal of Medicine2007;357(9):874‐84. [PUBMED: 17761591] MyburghJ , NealB , NortonR , McEvoyS , HayekM , SandercockP , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ2006;333(7577):1044‐6. [PUBMED: 17040925] ">Finfer 2004</a>; <a href="./references#CD000567-bbs2-0044" title="MyburghJ , BellomoR , CassA , FrenchJ , FinferS , GattasD , et al. The crystalloid versus hydroxyethyl starch trial: protocol for a multi‐centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Medicine2011;37(5):816‐23. [PUBMED: 21308360] MyburghJ , LiQ , HeritierS , DanA , GlassP . Statistical analysis plan for the crystalloid versus hydroxyethyl starch trial (CHEST). Critical Care &amp; Resuscitation2012;14(1):44‐52. Erratum appears in Critical Care &amp; Resuscitation 2012; 14(2):164. [PUBMED: 22404061] MyburghJA , FinferS , BellomoR , BillotL , CassA , GattasD , et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine2012;367(20):1901‐11. [PUBMED: 23075127] NCT00935168 . A multicentre randomized controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality. clinicaltrials.gov/ct2/show/NCT00935168 (first received 1 July 2009). [PUBMED: 23604905] PatelA , PieperK , MyburghJA , PerkovicV , FinferS , YangQ , et al. Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST). New England Journal of Medicine2017;377(3):298‐300. [PUBMED: 28723325] TaylorC , ThompsonK , FinferS , HigginsA , JanS , LiQ , et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long‐term outcomes and cost‐effectiveness analysis of a cohort from CHEST. Lancet Respiratory Medicine2016;4(10):818‐25. [PUBMED: 27324967] ">Myburgh 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trauma (includes studies of 'any trauma admissions', and head, chest, and abdominal injuries, and trauma with haemorrhagic or hypovolaemic shock) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>*; <a href="./references#CD000567-bbs2-0001" title="AlparEK , KillampalliVV . Effects of hypertonic dextran in hypovolaemic shock: a prospective clinical trial. Injury2004;35(5):500‐6. [PUBMED: 15081328] ">Alpar 2004</a>; <a href="./references#CD000567-bbs2-0003" title="BakerAJ , RhindSG , MorrisonLJ , BlackS , CrnkoNT , ShekPN , et al. Resuscitation with hypertonic saline‐dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Journal of Neurotrauma2009;26(8):1227‐40. [PUBMED: 19637968] ">Baker 2009</a>; <a href="./references#CD000567-bbs2-0007" title="BulgerEM , CuschieriJ , WarnerK , MaierRV . Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Annals of Surgery2007;245(4):635‐41. [PUBMED: 17414614] BulgerEM , JurkovichGJ , NathensAB , CopassMK , HansonS , CooperC , et al. Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Archives of Surgery2008;143(2):139‐48. [18283138] ">Bulger 2008</a>; <a href="./references#CD000567-bbs2-0008" title="BulgerEM , MayS , BraselKJ , SchreiberM , KerbyJD , TishermanSA , et al. Out‐of‐hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA2010;304(13):1455‐64. [PUBMED: 20924011] ">Bulger 2010</a>; <a href="./references#CD000567-bbs2-0009" title="BulgerEM , MayS , KerbyJD , EmersonS , StiellIG , SchreiberMA , et al. Out‐of‐hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery2011;253(3):431‐41. [PUBMED: 21178763] ">Bulger 2011</a>; <a href="./references#CD000567-bbs2-0018" title="EvansPA , GarnettM , BoffardK , KirkmanE , JacobsonBF . Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. Journal of the Royal Society of Medicine1996;89(2):101P. [PUBMED: 8683491] ">Evans 1996</a>; <a href="./references#CD000567-bbs2-0021" title="Grba‐BujevicM , Bosan‐KilibardaI , StrikicN . The use of hypertonic‐hyperoncotic solution for hypovolemic shock in trauma patients in prehospital setting. Neurologia Croatica2012;61(Suppl 2):21‐4. ">Grba‐Bujevic 2012</a>; <a href="./references#CD000567-bbs2-0025" title="JamesMF , MichellWL , JoubertIA , NicolAJ , NavsariaPH , GillespieRS . Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia2011;107(5):693‐702. [PUBMED: 21857015] ">James 2011</a>; <a href="./references#CD000567-bbs2-0030" title="LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid versus colloid in the etiology of pulmonary failure after trauma ‐ a randomized trial in man. Critical Care Medicine1979;7(3):107‐12. [PUBMED: 436425] LoweRJ , MossGS , JilekJ , LevineHD . Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery1977;81(6):676‐83. [PUBMED: 860200] MossGS , LoweRJ , JilekJ , LevineHD . Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery1981;89(4):434‐8. [PUBMED: 7010650] ">Lowe 1977</a>; <a href="./references#CD000567-bbs2-0032" title="CliftDR , LucasCE , LedgerwoodAM , SardesaiV , KithierK , GrabowD . The effect of albumin resuscitation for shock on the immune response to tetanus toxoid. Journal of Surgical Research1982;32(5):449‐52. [PUBMED: 7087432] JohnsonSD , LucasCE , GerrickSJ , LedgerwoodAM , HigginsRF . Altered coagulation after albumin supplements for treatment of oligemic shock. Archives of Surgery1979;114(4):379‐83. [PUBMED: 435053] LucasCE , BouwmanDL , LedgerwoodAM , HigginsR . Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. Journal of Trauma‐Injury Infection &amp; Critical Care1980;20(1):47‐51. [PUBMED: 7351677] LucasCE , WeaverD , HigginsRF , LedgerwoodAM , JohnsonSD , BouwmanDL . Effects of albumin versus non‐albumin resuscitation on plasma volume and renal excretory function. Journal of Trauma‐Injury Infection &amp; Critical Care1978;18(8):564‐70. [PUBMED: 682218] WeaverDW , LedgerwoodAM , LucasCE , HigginsR , BouwmanDL , JohnsonSD . Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Archives of Surgery1978;113(4):387‐92. [PUBMED: 637709] ">Lucas 1978</a>; <a href="./references#CD000567-bbs2-0037" title="MasoumiK , ForouzanA , DarianAA , Rafaty NavaiiA . Comparison of the effectiveness of hydroxyethyl starch (Voluven) solution with normal saline in hemorrhagic shock treatment in trauma. Journal of Clinical Medicine Research2016;8(11):815‐8. [PUBMED: 27738483] ">Masoumi 2016</a>; <a href="./references#CD000567-bbs2-0038" title="MattoxKL , ManingasPA , MooreEE , MateerJR , MarxJA , AprahamianC , et al. Prehospital hypertonic saline/dextran infusion for post‐traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery1991;213(5):482‐91. [PUBMED: 1708984] ">Mattox 1991</a>; <a href="./references#CD000567-bbs2-0043" title="MorrisonLJ , BakerAJ , RhindSG , KissA , MacDonaldRD , SchwartzB , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. Journal of Critical Care2011;26(4):363‐72. [PUBMED: 51162409] MorrisonLJ , RizoliSB , SchwartzB , RhindSG , SimitcuiM , PerreiraT , et al. The Toronto prehospital hypertonic resuscitation‐head injury and multiorgan dysfunction trial (TOPHR‐HIT) ‐ methods and data collection tools. Trials2009;10:105. [DOI: 10.1186/1745‐6215‐10‐105] RhindSG , CrnkoNT , BakerAJ , MorrisonLJ , ShekPN , ScarpeliniS , et al. Prehospital resuscitation with hypertonic saline‐dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. Journal of Neuroinflammation2010;7:5. [PUBMED: 20082712] ">Morrison 2011</a>; <a href="./references#CD000567-bbs2-0055" title="ShahDM , BrownerBD , DuttonRE , NewellJC , PowersJCJr . Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Archives of Surgery1977;112(10):1161‐8. [PUBMED: 907460] ">Shah 1977</a>; <a href="./references#CD000567-bbs2-0058" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Progress in Clinical and Biological Research1989;299:331‐8. [PUBMED: 2471213] VassarMJ , PerryCA , HolcroftJW . Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Archives of Surgery1990;125(10):1309‐15. Erratum in Archives of Surgery 1991; 126(1):43. [PUBMED: 1699508] ">Vassar 1990</a>; <a href="./references#CD000567-bbs2-0059" title="HolcroftJW , VassarMJ , PerryCA , GannawayWL , KramerGC . Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Brazilian Journal of Medical &amp; Biological Research1989;22(2):291‐3. [PUBMED: 2477096] HolcroftJW , VassarMJ , TurnerJE , DerletRW , KramerGC . 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Annals of Surgery1987;206(3):279‐88. [PUBMED: 2443087] VassarMJ , PerryCA , GannawayWL , HolcroftJW . 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Archives of Surgery1991;126(9):1065‐72. [PUBMED: 1718243] ">Vassar 1991</a>; <a href="./references#CD000567-bbs2-0060" title="VassarMJ , FischerRP , O'BrienPE , BachulisBL , ChambersJA , HoytDB , et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Archives of Surgery1993;128(9):1003‐11; discussion 1011‐3. [PUBMED: 7690225] ">Vassar 1993a</a>; <a href="./references#CD000567-bbs2-0061" title="VassarMJ , PerryCA , HolcroftJW . Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. Journal of Trauma1993;34(5):622‐32; discussion 632‐3. [PUBMED: 7684457] ">Vassar 1993b</a>; <a href="./references#CD000567-bbs2-0064" title="WuJJ , HuangMS , TangGJ , KaoWF , ShihHC , SuCH , et al. Hemodynamic response of modified fluid gelatin compared with lactated Ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial. World Journal of Surgery2001;25(5):598‐602. [PUBMED: 11369986] ">Wu 2001</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sepsis or septic shock</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>*; <a href="./references#CD000567-bbs2-0006" title="BrunkhorstFM , EngelC , BloosF , Meier‐HellmannA , RagallerM , WeilerN , et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine2008;358(2):125‐39. [PUBMED: 351096686] ">Brunkhorst 2008</a>; <a href="./references#CD000567-bbs2-0010" title="CaironiP , MassonS , TommasoM , BottazziB , RobertoL , MichelaM , et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. European Journal of Clinical Investigation2017;47(1):73‐83. [PUBMED: 27864924] CaironiP , TognoniG , MassonS , FumagalliR , PesentiA , RomeroM , et al. Albumin replacement in patients with severe sepsis or septic shock. New England Journal of Medicine2014;370(15):1412‐21. [PUBMED: 24635772] ">Caironi 2014</a>; <a href="./references#CD000567-bbs2-0015" title="DubinA , PozoMO , CasabellaCA , MuriasG , PalizasFJr , MoseincoMC , et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal‐directed therapy of septic patients. Journal of Critical Care2010;25(4):659.e1‐8. [PUBMED: 20813485] ">Dubin 2010</a>; <a href="./references#CD000567-bbs2-0017" title="ErnestD , BelzbergAS , DodekPM . Distribution of normal saline and 5% albumin infusions in septic patients. Critical Care Medicine1999;27(1):46‐50. [PUBMED: 9934892] ">Ernest 1999</a>; <a href="./references#CD000567-bbs2-0022" title="GuidetB , MartinetO , BoulainT , PhilippartF , PousselJF , MaizelJ , et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Critical Care2012;16(3):R94. [PUBMED: 22624531] ">Guidet 2012</a>; <a href="./references#CD000567-bbs2-0027" title="JieL , TongL , FangL , YouzhongA . The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock. Chinese Critical Care Medicine2015;27(1):28‐32. [PUBMED: 25591433] ">Jie 2015</a>; <a href="./references#CD000567-bbs2-0029" title="LiF , SunH , HanXD . The effect of different fluids on early fluid resuscitation in septic shock. Chinese Critical Care Medicine2008;20(8):472‐5. [PUBMED: 18687174] ">Li 2008</a>; <a href="./references#CD000567-bbs2-0031" title="LuJ , ZhaoHY , LiuF , AnYZ . The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Chinese Critical Care Medicine2012;24(1):38‐41. [PUBMED: 22248750] ">Lu 2012</a>; <a href="./references#CD000567-bbs2-0033" title="MahrousA , ElsammkM , MegahedM , ZytounT . Renal effect of colloid versus crystalloid in septic neutropenic patients. Critical Care Medicine2013;1:A250. [PUBMED: 71534173] ">Mahrous 2013</a>; <a href="./references#CD000567-bbs2-0039" title="McIntyreLA , FergussonD , CookDJ , RankinN , DhingraV , GrantonJ , et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Canadian Journal of Anaesthesia2008;55(12):819‐26. [PUBMED: 19050085] ">McIntyre 2008</a>; <a href="./references#CD000567-bbs2-0040" title="McIntyreLA , FergussonDA , CookDJ , RoweBH , BagshawSM , EastonD , et al. Fluid resuscitation with 5% albumin versus normal saline in early septic shock: a pilot randomized, controlled trial. Journal of Critical Care2012;27(3):317.e1‐6. [PUBMED: 22176806] ">McIntyre 2012</a>; <a href="./references#CD000567-bbs2-0042" title="ModigJ . Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic‐haemorrhagic shock. Resuscitation1983;10(4):219‐26. [PUBMED: 6196822] ModigJ . Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome. Critical Care Medicine1986;14(5):454‐7. [PUBMED: 16081356] ">Modig 1986</a>; <a href="./references#CD000567-bbs2-0048" title="OliveiraRP , WeingartnerR , RibasEO , MoraesRS , FriedmanG . Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Medicine2002;28(11):1574‐81. [PUBMED: 12415443] ">Oliveira 2002</a>; <a href="./references#CD000567-bbs2-0049" title="ParkC , OsawaE , AlmeidaJ , NakamuraR , DuayerI , FukushimaJ , et al. Lactated Ringer versus albumin in early sepsis therapy (RASP) study: preliminary data of a randomized controlled trial. Critical Care2015;1:S125. [PUBMED: 71938758] ">Park 2015</a> (cancer with sepsis); <a href="./references#CD000567-bbs2-0050" title="AnthonCT , MullerRB , HaaseN , HjortrupPB , MollerK , LangeT , et al. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis. Acta Anaesthesiologica Scandinavica2017;61(8):904‐13. [PUBMED: 28653377] HaaseN , WetterslevJ , WinkelP , PernerA . Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Medicine2013;39(12):2126‐34. [PUBMED: 24081433] HaaseN , WetterslevJ , WinkelP , PernerA . Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis: post‐hoc analyses of coagulation, bleeding and transfusion in a randomised trial. Intensive Care Medicine2013;39(2):S213. [DOI: https://doi‐org.ezproxy.lancs.ac.uk/10.1007/s00134‐013‐3111‐9] HaaseNR . Hydroxyethyl starch in sepsis. Danish Medical Journal2014;61(1):B4764. [PUBMED: 24393593] HjortrupPB , HaaseN , WetterslevJ , PernerA . Associations of hospital and patient characteristics with fluid resuscitation volumes in patients with severe sepsis: post hoc analyses of data from a multicentre randomised clinical trial. PLOS One2016;11(5):e0155767. [PUBMED: 27196104] MullerRB , HaaseN , LangeT , WetterslevJ , PernerA . Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis. Acta Anaesthesiologica Scandinavica2015;59(3):329‐36. [PUBMED: 25524831] MullerRB , OstrowskiSR , HaaseN , WetterslevJ , PernerA , JohanssonPI . Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate. Journal of Critical Care2016;32:16‐20. [PUBMED: 26810483] MullerRG , HaaseN , WetterslevJ , PernerA . Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post‐hoc analyses of a randomised trial. Intensive Care Medicine2013;39(11):1963‐71. [PUBMED: 24037226] PernerA , HaaseN , GuttormsenAB , TenhunenJ , KlemenzsonG , AnemanA , et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New England Journal of Medicine2012;367(2):124‐34. [PUBMED: 365216118] PernerA , HaaseN , WetterslevJ , AnemanA , TenhunenJ , GuttormsenAB , et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S‐‐Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double‐blinded, randomised clinical trial. Trials2011;12:24. [PUBMED: 21269526] PernerA , HaaseN , WinkelP , GuttormsenAB , TenhunenJ , KlemenzsonG , et al. Long‐term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate. Intensive Care Medicine2014;40(7):927‐34. [PUBMED: 24807084] ">Perner 2012</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>*; <a href="./references#CD000567-bbs2-0056" title="UpadhyayM , SinghiS , MurlidharanJ , KaurN , MajumdarS . Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatrics2005;42(3):223‐31. [PUBMED: 40461538] ">Upadhyay 2005</a>; <a href="./references#CD000567-bbs2-0069" title="ZhuGC , QuanZY , ShaoYS , ZhaoJG , ZhangYT . The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Chinese Critical Care Medicine2011;23(3):150‐3. [PUBMED: 361547296] ">Zhu 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hypovolaemia, hypovolaemic shock, haemorrhagic shock</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a>*; <a href="./references#CD000567-bbs2-0011" title="Chavez‐NegreteA , Majluf CruzS , Frati MunariA , PerchesA , ArgueroR . Treatment of hemorrhagic shock with intraosseous or intravenous infusion of hypertonic saline dextran solution. European Surgical Research1991;23(2):123‐9. [PUBMED: 1718756] ">Chavez‐Negrete 1991</a>; <a href="./references#CD000567-bbs2-0045" title="NagyKK , DavisJ , DudaJ , FildesJ , RobertsR , BarrettJ . A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circulatory Shock1993;40(4):289‐94. [PUBMED: 7690689] ">Nagy 1993</a>; <a href="./references#CD000567-bbs2-0054" title="HauptMT , RackowEC . Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Critical Care Medicine1982;10(3):159‐62. [PUBMED: 6174274] KaufmanBS , RackowEC , FalkJL . Fluid resuscitation in circulatory shock. Colloids versus crystalloids. Current Studies in Hematology &amp; Blood Transfusion1986;53:186‐98. [PUBMED: 3536330] RackowEC , FalkJL , FeinIA , SiegelJS , PackmanMI , HauptMT , et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Critical Care Medicine1983;11(11):839‐50. [PUBMED: 14245570] ">Rackow 1983</a>*; <a href="./references#CD000567-bbs2-0057" title="SmorenbergA , GroeneveldAB . Diuretic response to colloid and crystalloid fluid loading in critically ill patients. Journal of Nephrology2015;28(1):89‐95. [PUBMED: 24828327] Spoelstra‐de ManAM , SmorenbergA , GroeneveldAB . Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid‐base status in the critically ill. PLOS One2017;12(4):e0174507. [PUBMED: 28380062] TrofRJ , SukulSP , TwiskJW , GirbesAR , GroeneveldAB . Greater cardiac response of colloid than saline fluid loading in septic and non‐septic critically ill patients with clinical hypovolaemia. Intensive Care Medicine2010;36(4):697‐701. [PUBMED: 20165941] Van derHeijdenM , VerheijJ , VanNieuw AmerongenGP , GroeneveldAB . Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Critical Care Medicine2009;37(4):1275‐81. [PUBMED: 19242338] ">Van der Heijden 2009</a>; <a href="./references#CD000567-bbs2-0065" title="YounesRN , AunF , AcciolyCQ , CasaleLP , SzajnbokI , BiroliniD . Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery1992;111(4):380‐5. [PUBMED: 1373007] ">Younes 1992</a>; <a href="./references#CD000567-bbs2-0066" title="YounesRN , AunF , ChingC , GoldenbergD , FrancoM , MiuraF , SantosS , et al. Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients. Program and abstracts. International Conference on Hypertonic Resuscitation (6th) (SALT 6); 1994 Jun 2‐3; Teton Village (WY). 1994. YounesRN , AunF , ChingCT , GoldenbergDC , FrancoMH , MiuraFK , et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (Augusta, Ga.)1997;7(2):79‐83. [PUBMED: 9035281] ">Younes 1997</a>; <a href="./references#CD000567-bbs2-0067" title="YounesRN , YinKC , AminoCJ , ItinosheM , Rochae Silva M , BiroliniD . Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World Journal of Surgery1998;22(1):2‐5. [PUBMED: 9465753] ">Younes 1998</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0004" title="BechirM , PuhanMA , FasshauerM , SchuepbachRA , StockerR , NeffTA . Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double‐blind clinical trial. Critical Care2013;17(6):R299. [PUBMED: 24365167] ">Bechir 2013</a>; <a href="./references#CD000567-bbs2-0013" title="CooperAB , CohnSM , ZhangHS , HannaK , StewartTE , SlutskyAS . Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion2006;46(1):80‐9. [PUBMED: 16398734] ">Cooper 2006</a>; <a href="./references#CD000567-bbs2-0020" title="GoodwinCW , DorethyJ , LamV , PruittBAJr . Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Annals of Surgery1983;197(5):520‐31. [PUBMED: 6342554] ">Goodwin 1983</a>; <a href="./references#CD000567-bbs2-0023" title="HallK , SorensonB . The treatment of burn shock: results of a 5‐year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution. Burns1978;5(1):107‐12. HallKV , SorensenB . The treatment of burn shock. A comparative controlled trial of treatment by colloid infusion (Dextran saline), and by exclusively electrolyte infusion (Ringer lactate). Scandinavian Journal of Plastic and Reconstructive Surgery 173;7(1):67‐73. [PUBMED: 4752572] ">Hall 1978</a>; <a href="./references#CD000567-bbs2-0026" title='JelenkoC3rd , SolenbergerRI , WheelerML , CallawayBD . Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD. JACEP1979;8(7):253‐6. [PUBMED: 449157] JelenkoC3rd , WheelerML , CallawayBD , DivilioLT , BucklenKR , HoldredgeTD . Shock and resuscitation. II: volume repletion with minimal edema using the "HALFD" (Hypertonic Albuminated Fluid Demand) regimen. JACEP1978;7(9):326‐33. [PUBMED: 45702] JelenkoC3rd , WilliamsJB , WheelerML , CallawayBD , FacklerVK , AlbersCA , et al. Studies in shock and resuscitation, I: use of a hypertonic, albumin‐containing, fluid demand regimen (HALFD) in resuscitation. Critical Care Medicine1979;7(4):157‐67. [PUBMED: 446052] '>Jelenko 1979</a>; <a href="./references#CD000567-bbs2-0047" title="O'MaraMS , SlaterH , GoldfarbIW , CaushajPF . A prospective, randomized evaluation of intra‐abdominal pressures with crystalloid and colloid resuscitation in burn patients. Journal of Trauma2005;58(5):1011‐8. [PUBMED: 15920417] ">O'Mara 2005</a>; <a href="./references#CD000567-bbs2-0062" title="VlachouE , GoslingP , MoiemenNS . Hydroxyethylstarch supplementation in burn resuscitation ‐ a prospective randomised controlled trial. Burns2010;36(7):984‐91. [PUBMED: 20558004] ">Vlachou 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ALI, ARDS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0036" title="MartinGS , MossM , WheelerAP , MealerM , MorrisJA , BernardGR . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine2005;33(8):1681‐7. [PUBMED: 16096441] ">Martin 2005</a>; <a href="./references#CD000567-bbs2-0053" title="QuinlanGJ , MumbyS , MartinGS , BernardGR , GutteridgeJM , EvansTW . Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine2004;32(3):755‐9. [PUBMED: 15090958] ">Quinlan 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spontaneous subarachnoid haemorrhage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0005" title="BentsenG , BreivikH , LundarT , StubhaugA . Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo‐controlled study involving stable patients with subarachnoid hemorrhage. Critical Care Medicine2006;34(12):2912‐7. [17075367] ">Bentsen 2006</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dengue shock syndrome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0012" title="CifraHL , VelascoJN . A comparative study of the efficacy of 6% Haes‐Steril and Ringer's lactate in the management of dengue shock syndrome 555. Critical Care and Shock2003;2:95‐100. ">Cifra 2003</a>; <a href="./references#CD000567-bbs2-0016" title="DungNM , DayNP , TamDT , LoanHT , ChauHT , MinhLN , et al. Fluid replacement in dengue shock syndrome: a randomized, double‐blind comparison of four intravenous‐fluid regimens. Clinical Infectious Diseases1999;29(4):787‐94. [PUBMED: 10589889] ">Dung 1999</a>; <a href="./references#CD000567-bbs2-0063" title="WillsBA , DungNM , LoanHT , TamDT , ThuyTT , MinhLT , et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. New England Journal of Medicine2005;353(9):877‐89. [PUBMED: 16135832] ">Wills 2005</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postcardiac arrest</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0024" title="HeradstveitBE , GuttormsenAB , LangorgenJ , HammersborgS‐M , Wentzel‐LarsenT , FanebustR , et al. Capillary leakage in post‐cardiac arrest survivors during therapeutic hypothermia ‐ a prospective, randomised study. Scandinavian Journal of Trauma, Resuscitation &amp; Emergency Medicine2010;18:29. [PUBMED: 20500876] ">Heradstveit 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Perforation peritonitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0028" title="KumarS . Audit of preoperative fluid resuscitation in perforation peritonitis patients using physiological and operative severity score for enumeration of mortality and morbidity. Journal of Emergencies, Trauma and Shock2017;10(1):7‐12. [PUBMED: 28243006] ">Kumar 2017</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe malaria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0034" title="MaitlandK , PambaA , EnglishM , PeshuN , MarshK , NewtonC , et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clinical Infectious Diseases2005;40(4):538‐45. [PUBMED: 15712076 ] ">Maitland 2005</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe febrile illness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe pulmonary insufficiency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0041" title="MetildiLA , ShackfordSR , VirgilioRW , PetersRM . Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surgery, Gynecology &amp; Obstetrics1984;158(3):207‐12. [PUBMED: 6701732] ">Metildi 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vascular leak syndrome (cancer patients)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0052" title="PockajBA , YangJC , LotzeMT , LangeJR , SpencerWF , SteinbergSM , et al. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin‐2 therapy. Journal of Immunotherapy with Emphasis on Tumor Immunology1994;15(1):22‐8. [PUBMED: 8110727] ">Pockaj 1994</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cirrhosis and septic induced hypotension</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0051" title="PhilipsCA , ChoudhuryAK , SahneyA , MaiwallR , MitraLG , SarinSK . Comparison and outcomes of 5% albumin vs 0.9% normal saline fluid resuscitation in cirrhotics presenting with sepsis induced hypotension‐a randomized controlled trial‐fluid resuscitation in septic shock in cirrhosis (FRISC Protocol). Hepatology2015;62:261a. [Issn Print: 0270‐9139] ">Philips 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Severe acute pancreatitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0014" title="DuXJ , HuWM , XiaQ , HuangZW , ChenGY , JinXD , et al. Hydroxyethyl starch resuscitation reduces the risk of intra‐abdominal hypertension in severe acute pancreatitis. Pancreas2011;40(8):1220‐5. [PUBMED: 21775917] ">Du 2011</a>; <a href="./references#CD000567-bbs2-0068" title="ZhaoG , ZhangJ‐G , WuH‐S , TaoJ , QinQ , DengS‐C , et al. Effects of different resuscitation fluid on severe acute pancreatitis. World Journal of Gastroenterology2013;19(13):2044‐52. [PUBMED: 23599623] ">Zhao 2013</a> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>* included for more than one type of condition</p> <p><b>ALI:</b> acute lung injury<br/> <b>ARDS:</b> acute respiratory distress syndrome<br/> <b>ICU:</b> intensive care unit </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of participant conditions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD000567-tbl-0006"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Data for outcomes with a single study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Events in colloid group: n/N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Events in crystalloid group:</b> </p> <p><b>n/N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect estimate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Colloids (at the discretion of the clinician: HES, gelatins, or albumin) versus crystalloids</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Transfusion of blood products</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>377/1414</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>358/1443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.07, 95% CI 0.95 to 1.22; 2857 participants</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Renal replacement therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>156/1414</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>181/1443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.88, 95% CI 0.72 to 1.08; 2857 participants</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Gelatin versus crystalloids</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mortality (within 90 days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84/281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>346/1035</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.89, 95% CI 0.73 to 1.09; 1388 participants</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0002" title="AnnaneD , SiamiS , JaberS , MartinC , ElatrousS , DeclereAD , et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA2013;310(17):1809‐17. [PUBMED: 24108515] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open2017;7(10):e016736. [PUBMED: 28988172] HemingN , ElatrousS , JaberS , DumenilAS , CoussonJ , ForcevilleX , et al. Hemodynamic effects of crystalloids vs colloids: a subgroup analysis of the CRISTAL trial. Anaesthesiology Intensive Therapy2014;2:115‐6. [PUBMED: 28988172] ">Annane 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mortality (within 30 days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69/281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>275/1035</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.92, 95% CI 0.74 to 1.16; 1388 participants</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Albumin versus crystalloid</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD000567-bbs2-0035" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine2011;364(26):2483‐95. [PUBMED: 21615299] ">Maitland 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events: allergic reactions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/1050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/1047</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.75, 95% CI 0.17 to 3.33; 2097 participants</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><b>CI</b> : confidence interval<br/> <b>HES</b> : hydroxyethyl starch<br/> <b>n</b> : number of participants with an event<br/> <b>N</b> : number of participants randomised to group<br/> <b>RR</b>: risk ratio </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Data for outcomes with a single study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/full#CD000567-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000567-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Starches vs crystalloid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality at end of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.86, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mortality within 90 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mortality within 30 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.90, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Transfusion of blood product <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1917</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [1.02, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Renal replacement therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8527</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [1.14, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse event: allergic reaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7757</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.59 [0.27, 24.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse event: itching <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6946</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [1.05, 1.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Adverse event: rash <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [0.90, 2.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Starches vs crystalloid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000567-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Dextrans vs crystalloid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality at end of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4736</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.88, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mortality within 90 days and 30 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3353</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.87, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Transfusion of blood products <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.77, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse events: allergic reaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.0 [0.25, 144.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Dextrans vs crystalloid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000567-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Gelatins vs crystalloid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality at end of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1698</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.74, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Gelatins vs crystalloid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000567-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Albumin or FFP vs crystalloid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality at end of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13047</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.92, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mortality within 90 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12492</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.92, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mortality within 30 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12506</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.93, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Transfusion of blood product <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.95, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Renal replacement therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3028</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.96, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Albumin or FFP vs crystalloid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000567-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Dextrans vs crystalloid: subgroup by tonicity of crystalloid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality at end of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 colloid + hypertonic crystalloid vs isotonic crystalloid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2845</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.87, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 colloid + isotonic crystalloid vs hypertonic crystalloid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>493</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.62, 2.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 colloid + hypertonic crystalloid vs hypertonic crystalloid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>909</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.74, 1.41]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Dextrans vs crystalloid: subgroup by tonicity of crystalloid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000567.pub7/references#CD000567-tbl-0011">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000567.pub7&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD000567-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD000567-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000567-note-0021">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD000567-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD000567-note-0020">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD000567-note-0006">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD000567-note-0022">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD000567-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD000567-note-0004">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD000567-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD000567-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD000567-note-0019">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000567\x2epub7"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000567\x2epub7"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000567\x2epub7"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000567\x2epub7\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000567\x2epub7"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6XSHdtL3&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000567.pub7&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000567.pub7';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000567.pub7/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000567.pub7/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000567.pub7%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720367086"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000567.pub7/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720367089"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000567.pub7/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dff683a6f9377',t:'MTc0MDcyMDM2Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 